furosemide has been researched along with Body Weight in 299 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tolvaptan has been shown to improve congestion in heart failure patients." | 9.34 | Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure. ( Amitani, K; Iha, H; Imura, H; Ishihara, S; Ishikawa, M; Ishizuka, A; Ito, Y; Kikuchi, A; Kobayashi, N; Maruyama, Y; Mitsuishi, T; Nakama, K; Nakamura, S; Nohara, T; Ohkuma, S; Omote, T; Sato, N; Shigihara, S; Shimizu, W; Sone, M; Takagi, K; Takahashi, N; Tokuyama, H; Yamamoto, E, 2020) |
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 9.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 9.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
| "Satavaptan treatment was associated with a decrease in ascites (mean change in body weight was -0." | 9.14 | Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study. ( Bruha, R; Dudley, F; Ginès, P; Terg, R; Watson, H; Wong, F; Zarski, JP, 2010) |
| "Tolvaptan was orally administrated at titrated doses of 15, 30, and 60 mg once daily after breakfast for 3 days at each dose to 18 liver cirrhosis patients with persistent ascites and/or lower limb edema despite receiving oral furosemide at 40 mg/day or higher." | 9.14 | A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. ( Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N, 2010) |
| "To determine changes in RAS activation and clinical correlates following furosemide withdrawal in elderly heart failure patients without left ventricular systolic dysfunction." | 9.10 | Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. ( Hoefnagels, WH; Jansen, RW; Sweep, FC; van Kraaij, DJ, 2003) |
| "In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 9.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
| " All patients underwent at entry a physical examination, measurement of body weight (BW), blood pressure (BP), heart rate (HR), evaluation of signs of CHF, and controls of serum Na, K, Cl, bicarbonate, albumin, uric acid, creatinine, urea and glycemia and daily during hospitalization, as well as the daily output of urine for, Na, K and Cl measurements." | 9.09 | Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. ( Amato, P; Cardinale, A; Di Pasquale, P; Follone, G; Giubilato, A; Licata, G; Parrinello, G; Paterna, S, 2000) |
| "0 mg of nebulized furosemide per kilogram of body weight on pulmonary functions were studied in eight preterm infants with bronchopulmonary dysplasia who were supported by mechanical ventilation." | 9.07 | Nebulized furosemide in infants with bronchopulmonary dysplasia. ( Ajayi, OA; Luayon, M; Pildes, RS; Rastogi, A, 1994) |
| "The pharmacodynamics of torasemide (1-isopropyl-3- ([4-(3-methyl-phenylamino)pyridine]-3-sulfonyl)urea), a new potent loop diuretic, were compared to those of furosemide in a double-blind controlled study in 18 patients with oedema of various origin." | 9.06 | Comparative pharmacodynamics of torasemide and furosemide in patients with oedema. ( Broekhuysen, J; Deger, F; Douchamps, J; Ducarne, H; Herchuelz, A, 1988) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 9.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "Serum potassium levels, weight, heart function and patient's opinion of therapy were assessed in a study comparing 40 mg of frusemide and 600 mg of controlled-release potassium chloride in a combined tablet to frusemide and potassium supplements given as separate tablets in thirty elderly patients in cardiac failure." | 9.05 | A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure. ( Rao, CR, 1982) |
| "In a crossover study bumetanide, 2 to 6 mg/d, was compared with furosemide, 40 to 160 mg/d, in the treatment of 10 patients with the nephrotic syndrome and massive edema." | 9.05 | Treatment of nephrotic edema with bumetanide. ( Beauchemin, M; Gougoux, A; Lemieux, G; Vinay, P, 1981) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 9.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "The present study was undertaken to determine whether or not spironolactone could induce drug-metabolizing enzymes in patients with ascites due to alcoholic cirrhosis of the liver." | 9.05 | Spironolactone and enzyme induction in patients with alcoholic cirrhosis. ( Dhumeaux, D; Joanne, C; Miguet, JP; Thebault-Lucas, A; Vuitton, D, 1980) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 9.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "We investigated the effects of tolvaptan, a vasopressin V(2)-receptor antagonist, on diuretic response and systemic and renal hemodynamic characteristics in conscious dogs with congestive heart failure (CHF)." | 7.77 | Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. ( Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y, 2011) |
| "A previous study on furosemide-induced nephrocalcinosis (NC) showed only partial resolution of the calcifications after discontinuation of the diuretic." | 7.70 | Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Knoll, S, 2000) |
| "The effect of captopril on renal plasma flow (RPF), glomerular filtration rate (GFR), plasma concentrations of renin, angiotensin II (Ang II), aldosterone (Aldo) and arginine vasopressin (AVP), serum osmolality (Sosm), free water clearance (CLH2O), fractional urinary excretion of electrolytes and blood pressure (BP), was examined in 10 patients with moderate essential hypertension." | 7.67 | Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension. ( Danielsen, H; Pedersen, EB; Sørensen, SS; Thomsen, OO, 1986) |
| "We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics." | 7.67 | Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea. ( Cauchie, P; Decaux, G; Delwiche, F; Flamion, B; Mols, P, 1986) |
| " and muzolimine (M)/os in 10 patients with nephrotic syndrome (NS) and normal renal function." | 7.67 | Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption. ( Bazzato, G; Coli, U; Forte, M; Fracasso, A; Landini, S; Morachiello, P; Righetto, F; Scanferla, F, 1985) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 7.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "In an open multi-centre study, 51 patients with mild to moderate hypertension were treated with either a single dose of 40 mg penbutolol per day for 8 weeks or changed over at 4 weeks due to inadequate response with penbutolol alone to a single dose (1 tablet) of a fixed combination of 40 mg penbutolol and 20 mg furosemide per day for a further 4 weeks." | 7.66 | Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension. ( Graml, W; Haeringer, E; Rangoonwala, B; Roessner, M, 1982) |
| "Male and female, Sprague-Dawley rats, with and without arteriosclerosis, were subjected to chronic treatment with furosemide for 4 weeks." | 7.66 | Furosemide-induced hyperuricemia, hyperglycemia, hypertension and arterial lesions in nonarteriosclerotic and arteriosclerotic rats. ( Wexler, BC, 1981) |
| "Plasma concentrations of angiotensin II (AII) were studied in 36 patients with primary (essential) hypertension and 15 normotensive control subjects during basal (1 h supine rest), upright and frusemide-stimulated (80 mg orally) conditions." | 7.66 | Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes. ( Karlberg, BE; Tolagen, K, 1979) |
| " Symptomatic relief occurred as body weight was reduced, and after a 'dry' basal weight had been achieved, progressive-load exercise testing was done to examine any benefit that derived from adding oral digoxin to the diuretic." | 7.66 | The clinical value of digoxin in patients with heart failure and sinus rhythm. ( Guz, A; McHaffie, D; Mitchell-Heggs, P; Purcell, H, 1978) |
| "The effects of the new diuretic metolazone were studied in ten patients with chronic renal insufficiency and ten with nephrotic syndrome." | 7.65 | Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. ( Kane, RE; Paton, RR, 1977) |
| "The anti-hypertensive effect of spironolactone and thiabutazide was tested on 47 unselected patients with primary hypertension." | 7.65 | [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)]. ( Braun, B; Klaus, D; Klump, F; Lemke, R; Zehner, J; Zöfel, P, 1975) |
| "Metolazone is a potent thiazide-like diuretic." | 6.71 | Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. ( Galatius, S; Gustafsson, F; Hildebrandt, PR; Rosenberg, J, 2005) |
| " To develop an effective but safe regimen for treatment of cirrhotic ascites, a two-part crossover study was done." | 6.64 | An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide. ( Fuller, RK; Gobezie, GC; Khambatta, PB, 1977) |
| "Coexistent hepatocellular carcinoma (HCC) was the only significant predictive variable that attenuated the efficacy of TLV." | 5.46 | Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. ( Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M, 2017) |
| "CHF was characterized by left ventricular remodeling and impaired systolic and diastolic function." | 5.35 | Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. ( Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K, 2008) |
| "Tolvaptan has been shown to improve congestion in heart failure patients." | 5.34 | Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure. ( Amitani, K; Iha, H; Imura, H; Ishihara, S; Ishikawa, M; Ishizuka, A; Ito, Y; Kikuchi, A; Kobayashi, N; Maruyama, Y; Mitsuishi, T; Nakama, K; Nakamura, S; Nohara, T; Ohkuma, S; Omote, T; Sato, N; Shigihara, S; Shimizu, W; Sone, M; Takagi, K; Takahashi, N; Tokuyama, H; Yamamoto, E, 2020) |
| "This study aimed to assess the influence to the renal function by furosemide dose reductions after administration of tolvaptan in cirrhotic ascites patients." | 5.34 | Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis. ( Hidaka, H; Kako, M; Koizumi, W; Kubota, K; Nakazawa, T; Shibuya, A; Sung, JH; Tanaka, Y; Uojima, H; Wada, N, 2020) |
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 5.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "Then furosemide treatment was stopped and the rat food was changed to 1% NaCl diet." | 5.30 | Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats. ( Christensen, S; Haugan, K; Marcussen, N; Petersen, JS; Shalmi, M; Spannow, J, 1997) |
| "A 22 year old woman presented with lupus nephritis, hypertension, and intractable nephrotic syndrome." | 5.28 | Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. ( Friedler, A; Mor, F; Shapira, Y; Weinberger, A; Wysenbeek, AJ, 1990) |
| " The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 5.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
| "Ten patients with severe congestive heart failure (6 women and 4 men, aged 67 +/- 4." | 5.27 | Combination of furosemide and metolazone in the treatment of severe congestive heart failure. ( Grosskopf, I; Rabinovitz, M; Rosenfeld, JB, 1986) |
| "The combination of tolvaptan with conventional diuretics increases urine output without renal dysfunction and can be effective for postoperative fluid management and appropriate body weight reduction." | 5.22 | Effects of short-term administration of tolvaptan after open heart surgery. ( Iwahasi, T; Iwahori, A; Iwasaki, T; Koizumi, N; Maruno, K; Matsuyama, K; Nishibe, T; Ogino, H; Takahashi, S; Toguchi, K, 2016) |
| "The decrease in body weight from baseline to the day after the final dose with 15, 30 or 45 mg tolvaptan (-1." | 5.15 | Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. ( Asanoi, H; Hori, M; Izumi, T; Matsuzaki, M; Tsutamoto, T, 2011) |
| "Tolvaptan exerts diuretic effects and causes body weight loss at the low dose of 7." | 5.15 | Phase III clinical pharmacology study of tolvaptan. ( Hirayama, A; Hori, M; Inomata, T; Izumi, T; Matsuzaki, M, 2011) |
| "Satavaptan treatment was associated with a decrease in ascites (mean change in body weight was -0." | 5.14 | Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study. ( Bruha, R; Dudley, F; Ginès, P; Terg, R; Watson, H; Wong, F; Zarski, JP, 2010) |
| "Tolvaptan was orally administrated at titrated doses of 15, 30, and 60 mg once daily after breakfast for 3 days at each dose to 18 liver cirrhosis patients with persistent ascites and/or lower limb edema despite receiving oral furosemide at 40 mg/day or higher." | 5.14 | A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis. ( Chayama, K; Kaneko, A; Kato, M; Murawaki, Y; Okada, M; Okita, K; Ono, N; Sakaida, I; Sata, M; Yoshihara, H; Yoshihara, N, 2010) |
| "Our aim was to conduct a meta-analysis to evaluate the efficiency of combination HSS plus furosemide therapy in patients with ADHF in terms of mortality, readmissions, length of hospital stay, kidney function, urine output, body weight, and B-type natriuretic peptide (BNP)." | 5.12 | Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies. ( Afsar, B; Copur, S; Covic, A; Kanbay, M; Nistor, I; Siriopol, D; Tapoi, L; Ureche, C, 2021) |
| "To determine changes in RAS activation and clinical correlates following furosemide withdrawal in elderly heart failure patients without left ventricular systolic dysfunction." | 5.10 | Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function. ( Hoefnagels, WH; Jansen, RW; Sweep, FC; van Kraaij, DJ, 2003) |
| "In patients with CHF, tolvaptan was well tolerated; it reduced body weight and edema and normalized serum sodium in the hyponatremic patients." | 5.10 | Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. ( Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M, 2003) |
| " All patients underwent at entry a physical examination, measurement of body weight (BW), blood pressure (BP), heart rate (HR), evaluation of signs of CHF, and controls of serum Na, K, Cl, bicarbonate, albumin, uric acid, creatinine, urea and glycemia and daily during hospitalization, as well as the daily output of urine for, Na, K and Cl measurements." | 5.09 | Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure. ( Amato, P; Cardinale, A; Di Pasquale, P; Follone, G; Giubilato, A; Licata, G; Parrinello, G; Paterna, S, 2000) |
| "To evaluate the metabolic effects of two anti-hypertensive agents with different actions, nifedipine 20 mg twice daily and furosemide 60 mg twice daily, 23 patients with untreated essential hypertension performed a double-blind, cross-over study in treatment periods of 5 months." | 5.08 | Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study. ( Berne, C; Lind, L; Lithell, H; Pollare, T, 1995) |
| "0 mg of nebulized furosemide per kilogram of body weight on pulmonary functions were studied in eight preterm infants with bronchopulmonary dysplasia who were supported by mechanical ventilation." | 5.07 | Nebulized furosemide in infants with bronchopulmonary dysplasia. ( Ajayi, OA; Luayon, M; Pildes, RS; Rastogi, A, 1994) |
| "The effects of torasemide (20 mg/day) and furosemide (50 mg/day), each given over 4 days, were compared in a randomized and crossover study carried out in seven patients with cirrhosis and tense ascites." | 5.07 | Torasemide in the treatment of patients with cirrhosis and ascites. ( Carloni, V; Foschi, M; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Romanelli, RG, 1993) |
| "In the present study, circadian influences of furosemide on serum electrolytes, lipids and glucose were evaluated in ten hypertensive subjects." | 5.07 | Chronotherapeutic study of furosemide in hypertensive subjects: a preliminary report. ( Ebihara, A; Fujimura, A; Ohashi, K, 1991) |
| "The pharmacodynamics of torasemide (1-isopropyl-3- ([4-(3-methyl-phenylamino)pyridine]-3-sulfonyl)urea), a new potent loop diuretic, were compared to those of furosemide in a double-blind controlled study in 18 patients with oedema of various origin." | 5.06 | Comparative pharmacodynamics of torasemide and furosemide in patients with oedema. ( Broekhuysen, J; Deger, F; Douchamps, J; Ducarne, H; Herchuelz, A, 1988) |
| "The pharmacodynamic effects of torasemide, a new potent loop diuretic, were compared with those of furosemide in a double blind controlled study in 18 hypertensive patients with oedema of various origins." | 5.06 | Torasemide, a new potent diuretic. Double-blind comparison with furosemide. ( Broekhuysen, J; Deger, F; Douchamps, J; Ducarne, H; Herchuelz, A, 1986) |
| "A total of 95 patients seen in general practice with oedema associated with heart failure took part in an open study of the efficacy and tolerability of a combination tablet containing 40 mg frusemide and 5 mg amiloride." | 5.05 | Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice. ( Eason, CT; Richards, HH; Townsend, HA; Waddy, AL, 1984) |
| "Serum potassium levels, weight, heart function and patient's opinion of therapy were assessed in a study comparing 40 mg of frusemide and 600 mg of controlled-release potassium chloride in a combined tablet to frusemide and potassium supplements given as separate tablets in thirty elderly patients in cardiac failure." | 5.05 | A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure. ( Rao, CR, 1982) |
| "In a crossover study bumetanide, 2 to 6 mg/d, was compared with furosemide, 40 to 160 mg/d, in the treatment of 10 patients with the nephrotic syndrome and massive edema." | 5.05 | Treatment of nephrotic edema with bumetanide. ( Beauchemin, M; Gougoux, A; Lemieux, G; Vinay, P, 1981) |
| "To compare the efficacy of three commonly used diuretic regimens in the treatment of ascites, we randomized 90 patients to three treatment groups: Sequential Spironolactone (spironolactone followed by furosemide if necessary), Combination (spironolactone and furosemide in combination), and Furosemide (furosemide given alone)." | 5.05 | Diuresis in the ascitic patient: a randomized controlled trial of three regimens. ( Fogel, MR; Gregory, PB; Knauer, CM; Miller, RG; Neal, EA; Sawhney, VK, 1981) |
| "Forty patients completed a double-blind parallel group study comparing furosemide (FUR) and hydrochlorothiazide (HCT) when added to a stable dose of beta blocker in the treatment of mild to moderate hypertension." | 5.05 | Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension. ( Dombey, SL; Lawrence, J; Vander Elst, E; Vlassak, W, 1981) |
| "The present study was undertaken to determine whether or not spironolactone could induce drug-metabolizing enzymes in patients with ascites due to alcoholic cirrhosis of the liver." | 5.05 | Spironolactone and enzyme induction in patients with alcoholic cirrhosis. ( Dhumeaux, D; Joanne, C; Miguet, JP; Thebault-Lucas, A; Vuitton, D, 1980) |
| "The effects of various levels of sodium intake and loop diuretic (furosemide) administration upon arterial pressure and renal function were studied in 11 patients with impaired renal function and essential hypertension." | 5.04 | Sodium intake and furosemide administration in hypertensive patients with renal insufficiency. ( Davidov, ME; Finnerty, FA; Moir, D; Mroczek, WJ, 1977) |
| "This study was designed to compare the effectiveness of spironolactone, hydrochlorothiazide, and combined spironolactone-hydrochlorothiazide therapy in patients with low renin and those with normal renin essential hypertension." | 5.04 | Diuretic therapies in low renin and normal renin essential hypertension. ( Brooks, CS; Johnson, CA; Kotchen, JM; Kotchen, TA, 1977) |
| " Group A: In 14 patients with essential hypertension on chlorthalidone treatment, an additional daily dose of 640 mg propranolol for two months led to a significant reduction of the MAP (from 124 to 105 mm Hg) and PRA (from 5." | 5.04 | Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. ( Boer, P; Geyskes, GG; Leenen, FH; Mees, EJ; Vos, J, 1975) |
| "We investigated the effects of tolvaptan, a vasopressin V(2)-receptor antagonist, on diuretic response and systemic and renal hemodynamic characteristics in conscious dogs with congestive heart failure (CHF)." | 3.77 | Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure. ( Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y, 2011) |
| " The combination of FAD 286 A (30 mg/kg) and furosemide (30 mg/kg) on the HS diet corrected the diuretic-induced hypokalemia (4." | 3.73 | Investigation of aldosterone-synthase inhibition in rats. ( Bissery, A; Gonzalez, MF; Guyene, TT; Ménard, J, 2006) |
| "The purpose of this investigation was to study the effects of an equine nasal strip (NS), furosemide (Fur), and a combination of both (NS + Fur) on exercise-induced pulmonary hemorrhage (EIPH) at speeds corresponding to near-maximal effort." | 3.71 | Efficacy of nasal strip and furosemide in mitigating EIPH in Thoroughbred horses. ( Erickson, HH; Fenton, G; Kindig, CA; McDonough, P; Poole, DC, 2001) |
| "5 mL/kg of body weight (BW), PO], sucrose (2 g/kg in a 20% aqueous solution, p." | 3.70 | A reliable, practical, and economical protocol for inducing diarrhea and severe dehydration in the neonatal calf. ( Constable, PD; Drackley, JK; Foreman, JH; Morin, DE; Thurmon, JC; Walker, PG, 1998) |
| "A previous study on furosemide-induced nephrocalcinosis (NC) showed only partial resolution of the calcifications after discontinuation of the diuretic." | 3.70 | Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat. ( Alon, US; Knoll, S, 2000) |
| " To evaluate the influence of atrial natriuretic peptides on the ability of the kidneys, we also measured body weight, fluid balance, and the doses of furosemide and dopamine administered after the operation." | 3.70 | Preservation of the right atrial appendage improves reduced plasma atrial natriuretic peptide levels after the maze procedure. ( Hattori, R; Horio, T; Kangawa, K; Kitamura, S; Kobayashi, J; Kosakai, Y; Matsuo, H; Nishikimi, T; Ohe, T; Sasako, Y; Yoshihara, F, 2000) |
| "Changes in ischemic BW by fluid management correlated closely with changes in body weight except when high-dose mannitol was used." | 3.70 | Effects of fluid management on edema volume and midline shift in a rat model of ischemic stroke. ( Diringer, MN; He, YY; Hsu, CY; Lin, W; Paczynski, RP; Venkatesan, R, 2000) |
| "Three days of diuretic therapy with furosemide (oral and/or intravenous) for CHF was associated with a measured weight loss of 4." | 3.69 | Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure. ( Coodley, EL; Neutel, JM; Segal, JL; Smith, DH, 1995) |
| " The ratio of heart weight to body weight and left ventricular cavity dimension were significantly smaller in both amiloride groups than those in furosemide and control (untreated DCM) groups (p < 0." | 3.69 | Beneficial effect of amiloride, A Na(+)-H+ exchange blocker, in a murine model of dilated cardiomyopathy. ( Hasegawa, S; Imai, S; Kanda, T; Kobayashi, I; Nagai, R; Nakano, M; Suzuki, T; Taniguchi, Y, 1996) |
| " Furosemide administered to newborn pups induced a diuresis that resulted in a 11% to 22% loss in body weight and a concomitant decline in muscle water (13% to 16%) and sodium (18% to 21%)." | 3.67 | The effect of furosemide on intracranial pressure and hemorrhage in preterm rabbits. ( Greene, CS; Hornig, GW; Lorenzo, AV; Welch, K; Zavala, LM, 1989) |
| "Four white leghorn chickens were injected with furosemide (20 mg per kg body weight) three times at 12 h intervals and the kidneys fixed by perfusion after 36 h." | 3.67 | Peripolar cells in the avian kidney. ( Bohle, A; Christensen, JA; Mikeler, E; Morild, I, 1988) |
| "Alterations in electrolyte and acid-base balance were studied in 6 horses for 8 hours after furosemide administration (1 mg/kg of body weight, IM), and the results were compared with those for 5 healthy untreated horses (controls) kept under identical environmental conditions." | 3.67 | Influence of furosemide treatment on fluid and electrolyte balance in horses. ( Carlson, GP; Church, G; Freestone, JF; Harrold, DR, 1988) |
| "The effect of captopril on renal plasma flow (RPF), glomerular filtration rate (GFR), plasma concentrations of renin, angiotensin II (Ang II), aldosterone (Aldo) and arginine vasopressin (AVP), serum osmolality (Sosm), free water clearance (CLH2O), fractional urinary excretion of electrolytes and blood pressure (BP), was examined in 10 patients with moderate essential hypertension." | 3.67 | Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension. ( Danielsen, H; Pedersen, EB; Sørensen, SS; Thomsen, OO, 1986) |
| "We have studied the efficacy of urea in the treatment of hyponatremia and hydrosaline retention in cirrhotic patients with ascites resistant to diuretics." | 3.67 | Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea. ( Cauchie, P; Decaux, G; Delwiche, F; Flamion, B; Mols, P, 1986) |
| " and muzolimine (M)/os in 10 patients with nephrotic syndrome (NS) and normal renal function." | 3.67 | Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption. ( Bazzato, G; Coli, U; Forte, M; Fracasso, A; Landini, S; Morachiello, P; Righetto, F; Scanferla, F, 1985) |
| "A diuretic drug (40 mg of furosemide) was utilized to study the effects of dehydration (D) on competitive running performance, without prior thermal or exercise stress." | 3.67 | Influence of diuretic-induced dehydration on competitive running performance. ( Armstrong, LE; Costill, DL; Fink, WJ, 1985) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 3.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "Thirteen patients undergoing resection of benign prostatic hyperplasia were given furosemide 40 mg at the end of the procedure." | 3.66 | Changes in oncotic pressure, osmolality and electrolytes following transurethral resection of the prostate using glycine as irrigating solution. ( Breivik, H; Sellevold, O; Tveter, K, 1983) |
| "Muzolimine was administered by mouth to 24 patients with creatinine clearances ranging from 4 to 28 ml/min to treat oedema or hypertension, or both." | 3.66 | Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease. ( Andreucci, VE; Conte, G; Dal Canton, A; Gallo, R; Russo, D, 1981) |
| "In an open multi-centre study, 51 patients with mild to moderate hypertension were treated with either a single dose of 40 mg penbutolol per day for 8 weeks or changed over at 4 weeks due to inadequate response with penbutolol alone to a single dose (1 tablet) of a fixed combination of 40 mg penbutolol and 20 mg furosemide per day for a further 4 weeks." | 3.66 | Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension. ( Graml, W; Haeringer, E; Rangoonwala, B; Roessner, M, 1982) |
| "Male and female, Sprague-Dawley rats, with and without arteriosclerosis, were subjected to chronic treatment with furosemide for 4 weeks." | 3.66 | Furosemide-induced hyperuricemia, hyperglycemia, hypertension and arterial lesions in nonarteriosclerotic and arteriosclerotic rats. ( Wexler, BC, 1981) |
| "In patients with hypertension resistant to three or four drugs including a thiazide diuretic substitution of frusemide for the thiazide, or the addition of spironolactone, produced significant reductions in blood pressure and body weight." | 3.66 | Diuretic treatment of resistant hypertension. ( Freestone, S; Ramsay, LE; Silas, JH, 1980) |
| "Plasma concentrations of angiotensin II (AII) were studied in 36 patients with primary (essential) hypertension and 15 normotensive control subjects during basal (1 h supine rest), upright and frusemide-stimulated (80 mg orally) conditions." | 3.66 | Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes. ( Karlberg, BE; Tolagen, K, 1979) |
| "Twenty-four patients with hypertension were treated with chlorothiazide, chlorthalidone, and frusemide." | 3.66 | Duration of effect of different diuretics. ( Adam, WR; Hodgson, N; Morgan, TO; Myers, J, 1979) |
| " Symptomatic relief occurred as body weight was reduced, and after a 'dry' basal weight had been achieved, progressive-load exercise testing was done to examine any benefit that derived from adding oral digoxin to the diuretic." | 3.66 | The clinical value of digoxin in patients with heart failure and sinus rhythm. ( Guz, A; McHaffie, D; Mitchell-Heggs, P; Purcell, H, 1978) |
| "The effects of the new diuretic metolazone were studied in ten patients with chronic renal insufficiency and ten with nephrotic syndrome." | 3.65 | Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. ( Kane, RE; Paton, RR, 1977) |
| "To clarify the role of the enucleated adrenal in the suppression of plasma renin activity (PRA) in adrenal regeneration hypertension (ARH), PRA response to furosemide administration was compared at the 9th experimental week in three groups of rats, which had been subjected to (a) sham operation (control), (b) unilateral nephrectomy, (c) unilateral nephrectomy plus contralateral adrenal enucleation, and given on tap water or high sodium intakes." | 3.65 | Suppressed plasma renin activity in adrenal regeneration hypertension. ( Hasatani, K; Morimoto, S; Takeda, R, 1975) |
| "The anti-hypertensive effect of spironolactone and thiabutazide was tested on 47 unselected patients with primary hypertension." | 3.65 | [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)]. ( Braun, B; Klaus, D; Klump, F; Lemke, R; Zehner, J; Zöfel, P, 1975) |
| "1) To clarify the role of adrenal enucleation on plasma renin activity (PRA), plasma renin substrate (PRS), PRA response to furosemide administration and vacular reaction to renin in adrenal regeneration hypertension (ARH), serial changes of PRA and PRS during adrenal regeneration, PRA response to furosemide administration, and pressor response to exogenous renin in ARH were investigated by comparison with those of intact rats, unilaterally adrenalectomized rats, and unilaterally nephroadrenalectomized rats with contralateral adrenalectomy or with contralateral adrenal exploration (control) on both tap water and high sodium intake." | 3.65 | [Studies on the renin-angiotensin system in adrenal regeneration hypertension (author's transl)]. ( Hasatani, K, 1975) |
| "Pregnant rabbits were injected 12 mg 4-chloro-5-sulfamoyl-N-furfuryl-anthranilic acid (furosemide)/kg body weight from the first to the tenth day of pregnancy (o." | 3.65 | [Animal experiments on the "dysionic genesis of intrauterine malformations"]. ( Gödde, VE; Grote, W, 1975) |
| " One became oedema-free with frusemide 240 mg daily, three became oedema-free with frusemide 500 mg daily, and two required a combination of high-dose frusemide and spironolactone." | 3.65 | Salt-poor human albumin in management of nephrotic syndrome. ( Cash, JD; Davison, AM; Lambie, AT; Verth, AH, 1974) |
| "Body weight was recorded before (baseline) and 12 hours after treatment sessions ended and then after 5 minutes of soaking in a water bath." | 2.87 | Effects of furosemide administration to water-deprived inland bearded dragons (Pogona vitticeps). ( Mans, C; Parkinson, LA, 2018) |
| " Optimal control of BP remains elusive because of issues relating to drug dosage and proper choice of therapeutic agents, including questions regarding the role of diuretics." | 2.71 | Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling. ( Michelis, MF; Panagopoulos, G; Vlase, HL, 2003) |
| "Felodipine tended to increase U-AQP2, to decrease CH2O and urine volume and GFR, and to increase FENa, but the effect was not significantly different from placebo." | 2.71 | Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans. ( Bech, JN; Pedersen, EB; Starklint, J, 2005) |
| "Metolazone is a potent thiazide-like diuretic." | 2.71 | Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. ( Galatius, S; Gustafsson, F; Hildebrandt, PR; Rosenberg, J, 2005) |
| " This was in accordance with the pharmacokinetic behaviour of torasemide and furosemide." | 2.66 | Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. ( Brunner, G; Häcker, W; von Bergmann, K; von Möllendorff, E, 1988) |
| " To develop an effective but safe regimen for treatment of cirrhotic ascites, a two-part crossover study was done." | 2.64 | An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide. ( Fuller, RK; Gobezie, GC; Khambatta, PB, 1977) |
| "Coexistent hepatocellular carcinoma (HCC) was the only significant predictive variable that attenuated the efficacy of TLV." | 1.46 | Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. ( Goya, T; Kato, M; Kohjima, M; Kotoh, K; Masumoto, A; Miyazaki, M; Motomura, K; Senjyu, T; Tanaka, K; Yada, M, 2017) |
| " The effects of the high-fat diet trended in the opposite direction to that of IUGR, with increased drug exposure due to decreases in both clearance (31% males, 46% females) and volume of distribution (24% males, 44% females), with a 10% longer half-life in both genders." | 1.43 | Furosemide Pharmacokinetics in Adult Rats become Abnormal with an Adverse Intrauterine Environment and Modulated by a Post-Weaning High-Fat Diet. ( Cherala, G; DuBois, BN; Mahmood, T; Pearson, J; Thornburg, K, 2016) |
| "Treatment with furosemide or HCTZ did not have relevant effects on measured parameters." | 1.43 | The Effects of Early Postnatal Diuretics Treatment on Kidney Development and Long-Term Kidney Function in Wistar Rats. ( Bueters, RR; Florquin, S; Jeronimus-Klaasen, A; Maicas, N; Schreuder, MF; van den Heuvel, LP, 2016) |
| " In the present study, using guinea pigs we compared cochlear lesions induced by cisplatin administered in two regimens: consecutive application alone and in combination with furosemide." | 1.40 | Comparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide. ( Chen, Z; Su, K; Wang, J; Xia, L; Yin, S, 2014) |
| "Furosemide treatment significantly increased the urinary protein excretion when compared with the normal rats." | 1.40 | Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy. ( Afrin, R; Arumugam, S; Giridharan, VV; Harima, M; Karuppagounder, V; Miyashita, S; Pitchaimani, V; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K, 2014) |
| "CHF was characterized by left ventricular remodeling and impaired systolic and diastolic function." | 1.35 | Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure. ( Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K, 2008) |
| "Idiopathic nocturia is due to daytime volume expansion associated with the upright position." | 1.35 | Aging, circadian weight change, and nocturia. ( Kaye, M, 2008) |
| "Furosemide was used in 206 (49." | 1.34 | Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity. ( Kunitoh, H; Nokihara, H; Ohe, Y; Sekine, I; Tamura, T; Yamada, K; Yamamoto, N, 2007) |
| "To investigate the diuretic effects, tolerability, and adverse effects of furosemide and torsemide after short- and long-term administration in healthy dogs." | 1.34 | Effects of oral administration of furosemide and torsemide in healthy dogs. ( Higuchi, S; Hori, Y; Hoshi, F; Ikadai, H; Takusagawa, F; Uechi, M, 2007) |
| "Then furosemide treatment was stopped and the rat food was changed to 1% NaCl diet." | 1.30 | Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats. ( Christensen, S; Haugan, K; Marcussen, N; Petersen, JS; Shalmi, M; Spannow, J, 1997) |
| "4." | 1.29 | A micropuncture study of renal tubular lithium reabsorption in sodium-depleted rats. ( Sampson, B; Shirley, DG; Walter, SJ, 1995) |
| "Treatment with furosemide plus low-dose captopril increased plasma vasopressin but not plasma oxytocin." | 1.29 | Endocrine changes associated with a rapidly developing sodium appetite in rats. ( Johnson, AK; Morris, M; Thunhorst, RL, 1994) |
| "Effects of dehydration on thermoregulatory and metabolic responses were studied in six horses during 40 min of exercise eliciting approximately 40% of maximal O2 consumption and for 30 min after exercise." | 1.29 | Effects of dehydration on thermoregulatory responses of horses during low-intensity exercise. ( Bayly, WM; Brengelmann, GL; Gollnick, PD; Hodgson, DR; Naylor, JR, 1993) |
| " After oral administration, the extent of bioavailability increased considerably from 27." | 1.29 | Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. ( Choi, YM; Kim, SH; Lee, MG, 1993) |
| "Furosemide was added after the 3-week examination, and at 6 months, dogs had received furosemide for at least 4 months." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
| " Furosemide at dosage of 2 mg/kg reduced resting right atrial pressure (RAP) 4 hours after furosemide injection." | 1.28 | Influence of furosemide on hemodynamic responses during exercise in horses. ( Coyne, CP; Erickson, HH; Lowe, BS; Olsen, SC; Pelletier, N; Raub, EM, 1992) |
| "A 22 year old woman presented with lupus nephritis, hypertension, and intractable nephrotic syndrome." | 1.28 | Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. ( Friedler, A; Mor, F; Shapira, Y; Weinberger, A; Wysenbeek, AJ, 1990) |
| " Survival of dosed and control rats of both sexes and male mice was similar; survival of high-dose female mice was lower than controls." | 1.28 | Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 2. Furosemide. ( Bucher, JR; Davis, WE; Eustis, SL; Haseman, JK; Huff, J; Meierhenry, EF, 1990) |
| "Furosemide was administered as either an i." | 1.28 | Pharmacokinetics and dynamics of furosemide in the newborn piglet. ( Chapron, DJ; Kramer, PA; Miceli, JJ; Raye, JR; Rosenkrantz, TS, 1990) |
| " Diuretic agents allow dosing rate flexibilities because the temporal profile of diuretic action can vary considerably as long as the total diuretic effect per day is the same." | 1.28 | Optimization of the therapeutic index by adjustment of the rate of drug administration or use of drug combinations: exploratory studies of diuretics. ( Levy, G; Zhi, J, 1990) |
| " The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 1.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
| " A single dose of each compound was administered orally, or intraperitoneally, while multiple oral dosing was carried out once daily for a week." | 1.27 | [Effect of azosemide (SK-110) and its metabolites on mouse liver]. ( Asaeda, N; Haruyama, K; Ikawa, E; Koide, M; Shinoda, M; Tagawa, Y; Tamano, S, 1984) |
| "130 1 kg-1) but the elimination half-life was 70 +/- 20 min in the young and 102 +/- 33 min in the elderly (P less than 0." | 1.27 | The pharmacokinetics of frusemide are influenced by age. ( Andreasen, F; Hansen, U; Husted, SE; Jansen, JA, 1983) |
| " No differences between the dose-response curves of furosemide, bumetanide, or piretanide could be demonstrated." | 1.27 | Effect of diuretics on the tubuloglomerular feedback response. ( Brunkhorst, R; Franke, H; Gutsche, HU; Müller-Ott, K; Niedermayer, W, 1984) |
| "Eleven patients with acute congestive heart failure were studied during treatment with a loop diuretic." | 1.27 | The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. ( Anderson, JV; Bloom, SR; Woodruff, PW, 1988) |
| "Pretreatment with probenecid (240 mg kg-1 body weight) potentiated the hyperglycaemic effect of frusemide (25 or 200 mg kg-1 body weight)." | 1.27 | Probenecid potentiates the hyperglycaemic effect but reduces the diuretic effect of frusemide in mice. ( Sandström, PE, 1986) |
| "Ten patients with severe congestive heart failure (6 women and 4 men, aged 67 +/- 4." | 1.27 | Combination of furosemide and metolazone in the treatment of severe congestive heart failure. ( Grosskopf, I; Rabinovitz, M; Rosenfeld, JB, 1986) |
| "Furosemide-treated pups demonstrated a dose-dependent growth delay, decreased total bone (tibiae) Ca and Mg, increased urine Ca and Mg concentration, and a significant inverse correlation between bone Ca and urine Ca concentration." | 1.27 | Growth failure and decreased bone mineral of newborn rats with chronic furosemide therapy. ( Guan, ZP; Koo, WW; Laskarzewski, P; Neumann, V; Tsang, RC, 1986) |
| " M at a lower dosage than F has demonstrated an effective diuretic response irrespective the degree of renal impairment." | 1.27 | Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide. ( Bazzato, G; Coli, U; Fracasso, A; Landini, S; Morachiello, P; Righetto, F; Scanferla, F, 1985) |
| "Muzolimine is a diuretic with chemical features different from all other known diuretics, and its use seem to be particularly interesting in patients with chronic renal failure." | 1.27 | Muzolimine in chronic renal failure: a study in 16 patients. ( Colla, L; Dogliani, M; Squiccimarro, G; Stratta, P; Vercellone, A, 1985) |
| "Hyperaldosteronism is an important factor contributing to fluid and sodium retention in infants with heart failure." | 1.26 | The occurrence of hyperaldosteronism in infants with congestive heart failure. ( Baylen, BG; Johnson, G; Kaplan, S; Srivastava, L; Tsang, R, 1980) |
| "furosemide, the increase in PRA was dependent on the doses used per body weight, and was significantly correlated with the cumulative sodium excretion by itself, or the cumulative sodium excretion adjusted by either the leanness index or the body surface area." | 1.26 | Renin response to furosemide differs with the routes of administration in health men. ( Eto, T; Fukiyama, K; Kawasaki, T; Kumamoto, K; Noda, Y; Omae, T; Takishita, S, 1982) |
| "Furosemide was used to intensify the dehydration stimulus to determine whether such intensification could have caused the greater nucleolar changes when lactation and water deprivation were combined." | 1.26 | Water deprivation in lactating rats: changes in nucleolar dry mass of paraventricular and supraoptic neurones. ( Russell, JA, 1980) |
| "Studies were performed to evaluate the effects of the chronic administration of furosemide on hydrogen and electrolyte excretion in dogs on a normal electrolyte diet and in the absence of electrolyte or volume depletion." | 1.26 | Effect of chronic furosemide administration on hydrogen and sodium excretion in the dog. ( Bosch, JP; Goldstein, MH; Kahn, T; Levitt, MF, 1977) |
| "The animals were killed 48 hours after head trauma." | 1.26 | Effect of furosemide on experimental traumatic cerebral edema. ( McLaurin, RL; Sawaya, R; Tornheim, PA, 1979) |
| "Forty patients with generalized cancer complicated by water and electrolyte retention were treated with "medium" and "large" doses of furosemide and bumetanide with 35% and 40% objective positive response, respectively." | 1.26 | Diuretics in malignant effusions and edemas of generalized cancer. ( Athanasiou, A; Dadiotis, L; Razis, DV, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 190 (63.55) | 18.7374 |
| 1990's | 49 (16.39) | 18.2507 |
| 2000's | 31 (10.37) | 29.6817 |
| 2010's | 25 (8.36) | 24.3611 |
| 2020's | 4 (1.34) | 2.80 |
| Authors | Studies |
|---|---|
| Salahudin, M | 1 |
| Shah, H | 1 |
| Jan, MU | 1 |
| Altaf, A | 1 |
| Takagi, K | 1 |
| Sato, N | 1 |
| Ishihara, S | 1 |
| Iha, H | 1 |
| Kobayashi, N | 1 |
| Ito, Y | 1 |
| Nohara, T | 1 |
| Ohkuma, S | 1 |
| Mitsuishi, T | 1 |
| Ishizuka, A | 1 |
| Shigihara, S | 1 |
| Sone, M | 1 |
| Nakama, K | 1 |
| Tokuyama, H | 1 |
| Omote, T | 1 |
| Kikuchi, A | 1 |
| Nakamura, S | 2 |
| Yamamoto, E | 1 |
| Ishikawa, M | 1 |
| Amitani, K | 1 |
| Takahashi, N | 1 |
| Maruyama, Y | 1 |
| Imura, H | 1 |
| Shimizu, W | 1 |
| Covic, A | 1 |
| Copur, S | 1 |
| Tapoi, L | 1 |
| Afsar, B | 1 |
| Ureche, C | 1 |
| Siriopol, D | 1 |
| Nistor, I | 1 |
| Kanbay, M | 1 |
| Mose, FH | 1 |
| Oczachowska-Kulik, AE | 1 |
| Fenton, RA | 1 |
| Bech, JN | 2 |
| Miyazaki, M | 1 |
| Yada, M | 1 |
| Tanaka, K | 2 |
| Senjyu, T | 1 |
| Goya, T | 1 |
| Motomura, K | 1 |
| Kohjima, M | 1 |
| Kato, M | 2 |
| Masumoto, A | 1 |
| Kotoh, K | 1 |
| Uojima, H | 2 |
| Hidaka, H | 2 |
| Nakayama, T | 1 |
| Sung, JH | 2 |
| Ichita, C | 1 |
| Tokoro, S | 1 |
| Masuda, S | 1 |
| Sasaki, A | 1 |
| Koizumi, K | 1 |
| Egashira, H | 1 |
| Kako, M | 2 |
| Parkinson, LA | 1 |
| Mans, C | 1 |
| Tanaka, Y | 1 |
| Wada, N | 1 |
| Kubota, K | 1 |
| Nakazawa, T | 1 |
| Shibuya, A | 1 |
| Koizumi, W | 1 |
| Xia, L | 1 |
| Chen, Z | 1 |
| Su, K | 1 |
| Yin, S | 1 |
| Wang, J | 1 |
| Jefferies, JL | 1 |
| Bartone, C | 1 |
| Menon, S | 1 |
| Egnaczyk, GF | 1 |
| O'Brien, TM | 1 |
| Chung, ES | 1 |
| Marenzi, G | 1 |
| Muratori, M | 1 |
| Cosentino, ER | 1 |
| Rinaldi, ER | 1 |
| Donghi, V | 1 |
| Milazzo, V | 1 |
| Ferramosca, E | 1 |
| Borghi, C | 1 |
| Santoro, A | 1 |
| Agostoni, P | 1 |
| DuBois, BN | 2 |
| Pearson, J | 2 |
| Mahmood, T | 2 |
| Nguyen, D | 1 |
| Thornburg, K | 2 |
| Cherala, G | 2 |
| Arumugam, S | 1 |
| Sreedhar, R | 1 |
| Miyashita, S | 1 |
| Karuppagounder, V | 1 |
| Thandavarayan, RA | 1 |
| Giridharan, VV | 1 |
| Pitchaimani, V | 1 |
| Afrin, R | 1 |
| Harima, M | 1 |
| Suzuki, K | 1 |
| Watanabe, K | 2 |
| Ames, MK | 1 |
| Atkins, CE | 1 |
| Lee, S | 1 |
| Lantis, AC | 1 |
| zumBrunnen, JR | 1 |
| Bueters, RR | 1 |
| Jeronimus-Klaasen, A | 1 |
| Maicas, N | 1 |
| Florquin, S | 1 |
| van den Heuvel, LP | 1 |
| Schreuder, MF | 1 |
| Matsuyama, K | 1 |
| Koizumi, N | 1 |
| Nishibe, T | 1 |
| Iwasaki, T | 1 |
| Iwahasi, T | 1 |
| Toguchi, K | 1 |
| Takahashi, S | 1 |
| Iwahori, A | 1 |
| Maruno, K | 1 |
| Ogino, H | 1 |
| Core, SL | 1 |
| Curtis, KS | 1 |
| Vivier, PH | 1 |
| Blondiaux, E | 1 |
| Dolores, M | 1 |
| Marouteau-Pasquier, N | 1 |
| Brasseur, M | 1 |
| Petitjean, C | 1 |
| Dacher, JN | 1 |
| Andrade-Franzé, GM | 1 |
| Andrade, CA | 1 |
| De Luca, LA | 1 |
| De Paula, PM | 1 |
| Menani, JV | 1 |
| Németh, I | 1 |
| Nyitrai, V | 1 |
| Németh, A | 1 |
| Altbäcker, V | 1 |
| Ginès, P | 1 |
| Wong, F | 1 |
| Watson, H | 1 |
| Terg, R | 1 |
| Bruha, R | 1 |
| Zarski, JP | 1 |
| Dudley, F | 1 |
| Okita, K | 1 |
| Sakaida, I | 1 |
| Okada, M | 1 |
| Kaneko, A | 1 |
| Chayama, K | 1 |
| Sata, M | 1 |
| Yoshihara, H | 1 |
| Yoshihara, N | 1 |
| Ono, N | 1 |
| Murawaki, Y | 1 |
| Matsuzaki, M | 2 |
| Hori, M | 2 |
| Izumi, T | 2 |
| Asanoi, H | 1 |
| Tsutamoto, T | 1 |
| Onogawa, T | 1 |
| Sakamoto, Y | 1 |
| Nakayama, S | 1 |
| Fujiki, H | 1 |
| Yamamura, Y | 1 |
| Inomata, T | 1 |
| Hirayama, A | 1 |
| Udelson, JE | 1 |
| Bilsker, M | 1 |
| Hauptman, PJ | 1 |
| Sequeira, R | 1 |
| Thomas, I | 1 |
| O'Brien, T | 1 |
| Zimmer, C | 1 |
| Orlandi, C | 2 |
| Konstam, MA | 1 |
| Lu, B | 1 |
| Yan, J | 1 |
| Yang, X | 1 |
| Li, J | 1 |
| Chen, K | 1 |
| Thunhorst, RL | 3 |
| Johnson, AK | 3 |
| Coleman, RJ | 1 |
| St Lawrence, AC | 1 |
| Lawrence, LM | 1 |
| Roberts, AM | 1 |
| Wilson, WL | 1 |
| Starbuck, EM | 2 |
| Fitts, DA | 2 |
| van Kraaij, DJ | 1 |
| Jansen, RW | 2 |
| Sweep, FC | 1 |
| Hoefnagels, WH | 2 |
| Vlase, HL | 1 |
| Panagopoulos, G | 1 |
| Michelis, MF | 1 |
| Lundy, RF | 1 |
| Blair, M | 1 |
| Horvath, N | 1 |
| Norgren, R | 1 |
| Gheorghiade, M | 1 |
| Niazi, I | 1 |
| Ouyang, J | 1 |
| Czerwiec, F | 1 |
| Kambayashi, J | 1 |
| Zampino, M | 1 |
| Mank, A | 1 |
| Semin-Goossens, A | 1 |
| Lelie, Jv | 1 |
| Bakker, P | 1 |
| Vos, R | 1 |
| Starklint, J | 1 |
| Pedersen, EB | 2 |
| Rosenberg, J | 1 |
| Gustafsson, F | 1 |
| Galatius, S | 1 |
| Hildebrandt, PR | 1 |
| Stichtenoth, DO | 1 |
| Marhauer, V | 1 |
| Tsikas, D | 1 |
| Gutzki, FM | 1 |
| Frölich, JC | 2 |
| Berné, Y | 1 |
| Carías, D | 1 |
| Cioccia, AM | 1 |
| González, E | 1 |
| Hevia, P | 1 |
| Ménard, J | 2 |
| Gonzalez, MF | 1 |
| Guyene, TT | 1 |
| Bissery, A | 1 |
| Lee, HW | 1 |
| Kim, WY | 1 |
| Song, HK | 1 |
| Yang, CW | 1 |
| Han, KH | 1 |
| Kwon, HM | 1 |
| Kim, J | 1 |
| Forro, M | 1 |
| Lindinger, MI | 1 |
| Sekine, I | 1 |
| Yamada, K | 1 |
| Nokihara, H | 1 |
| Yamamoto, N | 1 |
| Kunitoh, H | 1 |
| Ohe, Y | 1 |
| Tamura, T | 1 |
| Hori, Y | 1 |
| Takusagawa, F | 1 |
| Ikadai, H | 1 |
| Uechi, M | 1 |
| Hoshi, F | 1 |
| Higuchi, S | 1 |
| Veeraveedu, PT | 1 |
| Ma, M | 1 |
| Palaniyandi, SS | 1 |
| Yamaguchi, K | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
| Kaye, M | 1 |
| Vorburger, C | 1 |
| Cottier, P | 1 |
| Wertheimer, L | 1 |
| Almondhiry, H | 1 |
| Khero, B | 1 |
| Edwards, KD | 1 |
| Sinnett, PF | 1 |
| Stewart, JH | 1 |
| Davidov, M | 2 |
| Kakaviatos, N | 1 |
| Finnerty, FA | 3 |
| Shafei, AZ | 1 |
| Habib, YA | 1 |
| el-Khangry, HA | 1 |
| Abou-Khair, SA | 1 |
| Abaza, HH | 1 |
| Nibal, AH | 1 |
| Javier, R | 1 |
| Dumler, F | 1 |
| Park, JH | 1 |
| Bok, DV | 1 |
| Riley, RW | 1 |
| Levin, NW | 1 |
| Bauer, JH | 1 |
| Alpert, MA | 1 |
| Sellevold, O | 1 |
| Breivik, H | 1 |
| Tveter, K | 1 |
| Padfield, PL | 1 |
| Grekin, RJ | 1 |
| Nicholls, MG | 1 |
| Townsend, HA | 1 |
| Waddy, AL | 1 |
| Eason, CT | 1 |
| Richards, HH | 1 |
| Abramow, M | 1 |
| Cogan, E | 1 |
| Asaeda, N | 1 |
| Ikawa, E | 1 |
| Tamano, S | 1 |
| Tagawa, Y | 1 |
| Shinoda, M | 1 |
| Haruyama, K | 1 |
| Koide, M | 1 |
| Caldwell, JE | 1 |
| Ahonen, E | 1 |
| Nousiainen, U | 1 |
| Koolen, MI | 1 |
| van Brummelen, P | 1 |
| Andreasen, F | 3 |
| Hansen, U | 1 |
| Husted, SE | 1 |
| Jansen, JA | 1 |
| Pan, HY | 1 |
| Wang, RY | 1 |
| Chan, TK | 1 |
| Ridge, S | 1 |
| Patak, RV | 1 |
| Savin, VJ | 1 |
| Gutsche, HU | 1 |
| Brunkhorst, R | 1 |
| Müller-Ott, K | 1 |
| Franke, H | 1 |
| Niedermayer, W | 1 |
| Bazzato, G | 3 |
| Coli, U | 3 |
| Landini, S | 3 |
| Lucatello, S | 1 |
| Fracasso, A | 3 |
| Righetto, F | 3 |
| Scanferla, F | 3 |
| Morachiello, P | 3 |
| Rao, CR | 1 |
| Dal Canton, A | 2 |
| Russo, D | 1 |
| Gallo, R | 1 |
| Conte, G | 2 |
| Andreucci, VE | 2 |
| Baylen, BG | 1 |
| Johnson, G | 1 |
| Tsang, R | 1 |
| Srivastava, L | 1 |
| Kaplan, S | 1 |
| Goldiner, WH | 1 |
| Valente, WA | 1 |
| Hamilton, BP | 1 |
| Mersey, JH | 1 |
| Lemieux, G | 1 |
| Beauchemin, M | 1 |
| Gougoux, A | 1 |
| Vinay, P | 1 |
| Fogel, MR | 1 |
| Sawhney, VK | 1 |
| Neal, EA | 1 |
| Miller, RG | 1 |
| Knauer, CM | 1 |
| Gregory, PB | 1 |
| Noda, Y | 3 |
| Fukiyama, K | 4 |
| Kumamoto, K | 4 |
| Takishita, S | 3 |
| Eto, T | 1 |
| Kawasaki, T | 4 |
| Omae, T | 4 |
| Wollam, GL | 1 |
| Tarazi, RC | 2 |
| Bravo, EL | 2 |
| Dustan, HP | 2 |
| Kadar, D | 1 |
| Tang, BK | 1 |
| Conn, AW | 1 |
| Haeringer, E | 1 |
| Graml, W | 1 |
| Rangoonwala, B | 1 |
| Roessner, M | 1 |
| Freis, ED | 2 |
| Notargiacomo, A | 1 |
| Burris, JF | 1 |
| Wexler, BC | 1 |
| Furrer, J | 1 |
| Hess, OM | 1 |
| Kuhlmann, U | 1 |
| Satz, N | 1 |
| Siegenthaler, W | 1 |
| Vander Elst, E | 1 |
| Dombey, SL | 1 |
| Lawrence, J | 1 |
| Vlassak, W | 1 |
| Tongia, SK | 2 |
| Pru, C | 1 |
| Kjellstrand, CM | 1 |
| Friedberg, V | 1 |
| Miguet, JP | 1 |
| Vuitton, D | 1 |
| Thebault-Lucas, A | 1 |
| Joanne, C | 1 |
| Dhumeaux, D | 1 |
| George, CR | 1 |
| Burke, AM | 1 |
| Forssell, G | 1 |
| Nordlander, R | 1 |
| Orinius, E | 1 |
| Ramsay, LE | 1 |
| Silas, JH | 1 |
| Freestone, S | 1 |
| Russell, JA | 1 |
| Decaux, G | 2 |
| Waterlot, Y | 1 |
| Genette, F | 1 |
| Mockel, J | 1 |
| Milani, A | 1 |
| Ciammella, AM | 1 |
| Rossi, L | 1 |
| Amann, K | 1 |
| Neusüss, R | 1 |
| Ritz, E | 1 |
| Irzyniec, T | 1 |
| Wiest, G | 1 |
| Mall, G | 1 |
| Walter, SJ | 1 |
| Sampson, B | 1 |
| Shirley, DG | 1 |
| Wideman, RF | 1 |
| Ismail, M | 1 |
| Kirby, YK | 1 |
| Bottje, WG | 1 |
| Moore, RW | 1 |
| Vardeman, RC | 1 |
| Lind, L | 1 |
| Berne, C | 1 |
| Pollare, T | 1 |
| Lithell, H | 1 |
| Morris, M | 1 |
| Boussairi, EH | 1 |
| Sacquet, J | 1 |
| Sassard, J | 2 |
| Benzoni, D | 1 |
| Rastogi, A | 1 |
| Luayon, M | 1 |
| Ajayi, OA | 1 |
| Pildes, RS | 2 |
| Frankmann, SP | 1 |
| Broder, L | 1 |
| Dokko, JH | 1 |
| Smith, GP | 1 |
| Nakatsuka, T | 1 |
| Fujikake, N | 1 |
| Hasebe, M | 1 |
| Ikeda, H | 1 |
| Naylor, JR | 1 |
| Bayly, WM | 1 |
| Gollnick, PD | 1 |
| Brengelmann, GL | 1 |
| Hodgson, DR | 1 |
| Modena, B | 1 |
| Holmer, S | 1 |
| Eckardt, KU | 1 |
| Schricker, K | 1 |
| Riegger, G | 1 |
| Kaissling, B | 1 |
| Kurtz, A | 1 |
| Hubbell, CL | 1 |
| McCutcheon, NB | 1 |
| Dhaneria, SP | 1 |
| Nyati, P | 1 |
| Kuramochi, G | 1 |
| Homma, S | 1 |
| Cullen, MH | 1 |
| Kim, SH | 1 |
| Choi, YM | 1 |
| Lee, MG | 1 |
| Gentilini, P | 1 |
| Laffi, G | 1 |
| La Villa, G | 1 |
| Carloni, V | 1 |
| Foschi, M | 1 |
| Romanelli, RG | 1 |
| Marra, F | 1 |
| Coodley, EL | 1 |
| Segal, JL | 1 |
| Smith, DH | 1 |
| Neutel, JM | 1 |
| Taniguchi, Y | 1 |
| Nakano, M | 1 |
| Hasegawa, S | 1 |
| Kanda, T | 1 |
| Imai, S | 1 |
| Suzuki, T | 1 |
| Kobayashi, I | 1 |
| Nagai, R | 1 |
| Leshem, M | 1 |
| Maroun, M | 1 |
| Del Canho, S | 1 |
| Onyefuru, LC | 1 |
| Upshall, DG | 1 |
| Rice, P | 1 |
| Häggström, J | 1 |
| Hansson, K | 1 |
| Karlberg, BE | 2 |
| Kvart, C | 1 |
| Madej, A | 1 |
| Olsson, K | 1 |
| Kim, S | 1 |
| Hamaguchi, A | 1 |
| Shinkawa, T | 1 |
| Kato, Y | 1 |
| Tsuchiya, N | 1 |
| Miura, K | 1 |
| Ohta, K | 1 |
| Iwao, H | 1 |
| Haugan, K | 1 |
| Shalmi, M | 1 |
| Petersen, JS | 3 |
| Marcussen, N | 2 |
| Spannow, J | 1 |
| Christensen, S | 3 |
| Honrath, U | 1 |
| Veress, AT | 1 |
| Chong, CK | 1 |
| Sonnenberg, H | 1 |
| Olde Rikkert, MG | 1 |
| Deurenberg, P | 1 |
| van't Hof, MA | 1 |
| Romagnoli, C | 1 |
| Zecca, E | 1 |
| Papacci, P | 1 |
| De Carolis, MP | 1 |
| Giannini, R | 1 |
| Gallini, F | 1 |
| Tortorolo, G | 1 |
| Hinchcliff, KW | 1 |
| McKeever, KH | 1 |
| Pfeifer, M | 1 |
| Bruckschlegel, G | 1 |
| Holmer, SR | 1 |
| Paul, M | 1 |
| Riegger, AJ | 1 |
| Schunkert, H | 1 |
| Walker, PG | 1 |
| Constable, PD | 1 |
| Morin, DE | 1 |
| Drackley, JK | 1 |
| Foreman, JH | 1 |
| Thurmon, JC | 1 |
| Lane, PH | 1 |
| Tyler, LD | 1 |
| Schmitz, PG | 1 |
| Collister, JP | 1 |
| Osborn, JW | 1 |
| Lane, JR | 1 |
| Li, CP | 1 |
| Jonassen, TE | 1 |
| Sørensen, AM | 1 |
| Flyvbjerg, A | 1 |
| Haris, A | 1 |
| Radó, JP | 2 |
| Knoll, S | 1 |
| Alon, US | 1 |
| Yoshihara, F | 1 |
| Nishikimi, T | 1 |
| Sasako, Y | 1 |
| Kobayashi, J | 1 |
| Kosakai, Y | 1 |
| Hattori, R | 1 |
| Horio, T | 1 |
| Kitamura, S | 1 |
| Matsuo, H | 2 |
| Ohe, T | 1 |
| Kangawa, K | 2 |
| Paczynski, RP | 1 |
| Venkatesan, R | 1 |
| Diringer, MN | 1 |
| He, YY | 1 |
| Hsu, CY | 1 |
| Lin, W | 1 |
| Paterna, S | 1 |
| Di Pasquale, P | 1 |
| Parrinello, G | 1 |
| Amato, P | 1 |
| Cardinale, A | 1 |
| Follone, G | 1 |
| Giubilato, A | 1 |
| Licata, G | 1 |
| Nakahama, H | 1 |
| Obata, K | 1 |
| Sugita, M | 1 |
| Oka, K | 1 |
| Moriyama, T | 1 |
| Medcalf, JF | 1 |
| Harris, KP | 1 |
| Walls, J | 1 |
| Stein, MS | 1 |
| Flicker, L | 1 |
| Scherer, SC | 1 |
| Paton, LM | 1 |
| O'Brien, ML | 1 |
| Walton, SC | 1 |
| Chick, P | 1 |
| Di Carlantonio, M | 1 |
| Zajac, JD | 1 |
| Wark, JD | 1 |
| Kindig, CA | 1 |
| McDonough, P | 1 |
| Fenton, G | 2 |
| Poole, DC | 1 |
| Erickson, HH | 2 |
| Geor, RJ | 1 |
| Ommundson, L | 1 |
| Pagan, JD | 1 |
| Pires, SL | 1 |
| Julien, C | 1 |
| Chapuis, B | 1 |
| Barrès, C | 1 |
| Pedersen, OL | 1 |
| Bosch, JP | 1 |
| Goldstein, MH | 1 |
| Levitt, MF | 1 |
| Kahn, T | 1 |
| MacGregor, GA | 1 |
| Tasker, PR | 1 |
| de Wardener, HE | 1 |
| Hollifield, JW | 1 |
| Michelakis, AM | 1 |
| Vesper, BS | 1 |
| Wilson, JP | 1 |
| Shand, DG | 1 |
| Seyberth, HJ | 1 |
| Frölich, WH | 1 |
| Oates, JA | 1 |
| Grim, CE | 1 |
| Weinberger, MH | 1 |
| Henry, DP | 1 |
| Luft, FC | 1 |
| Fineberg, NS | 1 |
| Fuller, RK | 1 |
| Khambatta, PB | 1 |
| Gobezie, GC | 1 |
| Mroczek, WJ | 2 |
| Moir, D | 1 |
| Davidov, ME | 1 |
| Brooks, CS | 1 |
| Johnson, CA | 1 |
| Kotchen, JM | 1 |
| Kotchen, TA | 1 |
| Araoye, MA | 1 |
| Chang, MY | 1 |
| Khatri, IM | 1 |
| Blendis, LM | 1 |
| Greig, PD | 1 |
| Langer, B | 1 |
| Baigrie, RS | 1 |
| Ruse, J | 1 |
| Taylor, BR | 1 |
| Tornheim, PA | 1 |
| McLaurin, RL | 1 |
| Sawaya, R | 1 |
| Biamino, G | 1 |
| Kopp, H | 1 |
| Rudroff, W | 1 |
| Schneider, B | 1 |
| Heims, F | 1 |
| Tolagen, K | 1 |
| Morgan, TO | 1 |
| Adam, WR | 1 |
| Hodgson, N | 1 |
| Myers, J | 1 |
| Ohtani, I | 1 |
| Ohtsuki, K | 1 |
| Omata, T | 1 |
| Ouchi, J | 1 |
| Saito, T | 1 |
| Rego Filho, Ede A | 1 |
| Casoni, W | 1 |
| Ruilope, LM | 1 |
| García-Robles, R | 1 |
| Mancheño, E | 1 |
| Rodríguez, FJ | 1 |
| Barrientos, A | 1 |
| Torres, J | 1 |
| Radicio, JL | 1 |
| Oriol-Bosch, A | 1 |
| Wälli, T | 1 |
| Engle, MA | 1 |
| Lewy, JE | 1 |
| Lewy, PR | 1 |
| Metcoff, J | 1 |
| McHaffie, D | 1 |
| Purcell, H | 1 |
| Mitchell-Heggs, P | 1 |
| Guz, A | 2 |
| Altman, J | 1 |
| Gordan, P | 1 |
| Grünfeld, JP | 1 |
| Valmin, K | 1 |
| Hansen, T | 1 |
| Wilson, M | 2 |
| Morgan, T | 2 |
| Gillies, A | 1 |
| Paton, RR | 1 |
| Kane, RE | 1 |
| Lopez-Novoa, JM | 1 |
| Rodicio-Diaz, JL | 1 |
| Hernando-Avendano, L | 1 |
| Kiprov, D | 1 |
| Dimitrov, T | 1 |
| Yamamoto, J | 1 |
| Howard, EJ | 1 |
| Mullin, EM | 1 |
| Bonar, RA | 1 |
| Kane, RD | 1 |
| Paulson, DF | 1 |
| Thiel, G | 1 |
| Brunner, F | 1 |
| Wunderlich, P | 1 |
| Huguenin, M | 1 |
| Bienko, B | 1 |
| Torhorst, J | 1 |
| Peters-Haefeli, L | 1 |
| Kirchertz, EJ | 1 |
| Peters, G | 1 |
| Razis, DV | 1 |
| Athanasiou, A | 1 |
| Dadiotis, L | 1 |
| Witchitz, S | 1 |
| Kamoun, A | 1 |
| Chiche, P | 1 |
| Geyskes, GG | 1 |
| Boer, P | 1 |
| Vos, J | 1 |
| Leenen, FH | 1 |
| Mees, EJ | 1 |
| Vereerstraeten, PJ | 1 |
| Dupuis, F | 1 |
| Toussaint, C | 1 |
| Hasatani, K | 2 |
| Morimoto, S | 1 |
| Takeda, R | 1 |
| Arruda, JA | 1 |
| Gutierrez, LF | 1 |
| Kurtzman, NA | 1 |
| López-Uriarte, A | 1 |
| Santos-Atherton, D | 2 |
| Yamamoto, Y | 1 |
| Oniki, H | 1 |
| Klump, F | 1 |
| Braun, B | 1 |
| Klaus, D | 1 |
| Lemke, R | 1 |
| Zehner, J | 1 |
| Zöfel, P | 1 |
| Gödde, VE | 1 |
| Grote, W | 1 |
| Hof, RP | 1 |
| Umemura, K | 1 |
| Evenou, JP | 1 |
| Hof, A | 1 |
| Rüegg, PC | 1 |
| Olsen, SC | 1 |
| Coyne, CP | 1 |
| Lowe, BS | 1 |
| Pelletier, N | 1 |
| Raub, EM | 1 |
| Fujimura, A | 2 |
| Ohashi, K | 2 |
| Ebihara, A | 2 |
| Tietze, I | 1 |
| Hansen, FA | 1 |
| Steiness, E | 1 |
| Brørs, O | 1 |
| Kuzemková, L | 1 |
| Stríbrná, J | 1 |
| Janata, V | 1 |
| Shapira, Y | 1 |
| Mor, F | 1 |
| Friedler, A | 1 |
| Wysenbeek, AJ | 1 |
| Weinberger, A | 1 |
| Bucher, JR | 1 |
| Huff, J | 1 |
| Haseman, JK | 1 |
| Eustis, SL | 1 |
| Davis, WE | 1 |
| Meierhenry, EF | 1 |
| Simpson, FO | 1 |
| Ledingham, JM | 1 |
| Miceli, JJ | 1 |
| Kramer, PA | 1 |
| Chapron, DJ | 1 |
| Rosenkrantz, TS | 1 |
| Raye, JR | 1 |
| Zhi, J | 1 |
| Levy, G | 1 |
| Becker, RH | 1 |
| Baldes, L | 1 |
| Treudler, M | 1 |
| Wilson, TW | 2 |
| McCaulay, FA | 1 |
| Waslen, TA | 1 |
| Lorenzo, AV | 2 |
| Greene, CS | 1 |
| Hornig, GW | 1 |
| Zavala, LM | 2 |
| Welch, K | 2 |
| Loon, NR | 1 |
| Wilcox, CS | 1 |
| Unwin, RJ | 1 |
| Perlman, JM | 1 |
| Moore, V | 1 |
| Siegel, MJ | 1 |
| Dawson, J | 1 |
| Kohno, M | 1 |
| Clegg, KB | 1 |
| Sambhi, MP | 1 |
| Anderson, JV | 1 |
| Woodruff, PW | 1 |
| Bloom, SR | 1 |
| Michel, JB | 1 |
| Dussaule, JC | 1 |
| Choudat, L | 1 |
| Auzan, C | 1 |
| Nochy, D | 1 |
| Corvol, P | 1 |
| Sasaki, H | 1 |
| Yamamoto, T | 2 |
| Ninomiya, H | 1 |
| Ono, J | 1 |
| Asano, T | 1 |
| Okumura, M | 1 |
| Cheba, L | 1 |
| Kowalska, K | 1 |
| Osei, K | 1 |
| Falko, JM | 1 |
| Morild, I | 1 |
| Christensen, JA | 1 |
| Mikeler, E | 1 |
| Bohle, A | 1 |
| Freestone, JF | 1 |
| Carlson, GP | 1 |
| Harrold, DR | 1 |
| Church, G | 1 |
| Green, TP | 1 |
| Johnson, DE | 1 |
| Bass, JL | 1 |
| Landrum, BG | 1 |
| Ferrara, TB | 1 |
| Thompson, TR | 1 |
| Brunner, G | 1 |
| von Bergmann, K | 1 |
| Häcker, W | 2 |
| von Möllendorff, E | 1 |
| Herchuelz, A | 2 |
| Deger, F | 2 |
| Douchamps, J | 2 |
| Ducarne, H | 2 |
| Broekhuysen, J | 2 |
| Kult, J | 1 |
| Glocke, M | 1 |
| Bolton, JP | 1 |
| Henderson, IW | 1 |
| McCauley, FA | 1 |
| Wells, HD | 1 |
| Thomsen, OO | 1 |
| Danielsen, H | 1 |
| Sørensen, SS | 1 |
| Borchgrevink, PC | 1 |
| Holten, T | 1 |
| Jynge, P | 1 |
| Fine, BP | 1 |
| Ty, A | 1 |
| Lestrange, N | 1 |
| Maher, E | 1 |
| Levine, OR | 1 |
| Kamm, DE | 1 |
| Wu, L | 1 |
| Kuchmy, BL | 1 |
| Aubert, P | 1 |
| Weil, G | 1 |
| Pockros, PJ | 1 |
| Reynolds, TB | 1 |
| Cunningham, JJ | 1 |
| Molnar, JA | 1 |
| Meara, PA | 1 |
| Bode, HH | 1 |
| Sandström, PE | 1 |
| Grosskopf, I | 1 |
| Rabinovitz, M | 1 |
| Rosenfeld, JB | 1 |
| Mols, P | 1 |
| Cauchie, P | 1 |
| Flamion, B | 1 |
| Delwiche, F | 1 |
| Hornig, G | 1 |
| Boss, V | 1 |
| Koo, WW | 1 |
| Guan, ZP | 1 |
| Tsang, RC | 1 |
| Laskarzewski, P | 1 |
| Neumann, V | 1 |
| Bealer, SL | 1 |
| Schneider, EG | 2 |
| Fuiano, G | 1 |
| Terribile, M | 1 |
| Sabbatini, M | 1 |
| Cianciaruso, B | 1 |
| Stratta, P | 2 |
| Dogliani, M | 2 |
| Squiccimarro, G | 1 |
| Colla, L | 1 |
| Vercellone, A | 1 |
| Forte, M | 1 |
| Ansuini, R | 1 |
| Pulido, M | 1 |
| Pupita, G | 1 |
| Gaggi, S | 1 |
| Pupita, F | 1 |
| Yeh, TF | 1 |
| Raval, D | 1 |
| John, E | 1 |
| Armstrong, LE | 1 |
| Costill, DL | 1 |
| Fink, WJ | 1 |
| Heidemann, HT | 1 |
| Gerkens, JF | 1 |
| Jackson, EK | 1 |
| Branch, RA | 1 |
| Mallie, JP | 1 |
| Gerard, A | 1 |
| Gerard, H | 1 |
| Kohner, EM | 1 |
| Dollery, CT | 1 |
| Lowy, C | 1 |
| Schumer, B | 1 |
| Hantman, D | 1 |
| Rossier, B | 1 |
| Zohlman, R | 1 |
| Schrier, R | 1 |
| Jenin, P | 1 |
| Lenoir, J | 1 |
| Bolot, J | 1 |
| Bernard, C | 1 |
| Thomasset, A | 1 |
| Whight, C | 1 |
| Carney, S | 1 |
| Perez, G | 1 |
| Siegel, L | 1 |
| Schreiner, GE | 1 |
| Liard, JF | 1 |
| Vecsei, P | 1 |
| Gless, KH | 1 |
| Winter, M | 1 |
| Hanka-Postozky, M | 1 |
| Dluhy, RG | 1 |
| Cain, JP | 1 |
| Williams, GH | 1 |
| Nolly, H | 1 |
| Fasciolo, JC | 1 |
| Lvoff, R | 1 |
| Wilcken, DE | 1 |
| Gottlieb, TB | 1 |
| Katz, FH | 2 |
| Chidsey, CA | 1 |
| Sharefkin, JB | 1 |
| Silen, W | 1 |
| Jamison, RL | 1 |
| Frey, NR | 1 |
| Lacy, FB | 1 |
| Rácz-Kotilla, E | 1 |
| Rácz, G | 1 |
| Solomon, A | 1 |
| Fukuchi, S | 1 |
| Nakajima, K | 1 |
| Takenouchi, T | 1 |
| Nishisato, K | 1 |
| Bradley, VE | 1 |
| Shier, MR | 1 |
| Lucas, CE | 1 |
| Rosenberg, IK | 1 |
| Herden, HN | 1 |
| Sadikali, F | 1 |
| Trinkle, JK | 1 |
| Furman, RW | 1 |
| Hinshaw, MA | 1 |
| Bryant, LR | 1 |
| Griffen, WO | 1 |
| Kalos, A | 1 |
| Dixon, AS | 1 |
| Weber, JC | 1 |
| Hastings, SG | 1 |
| Johnston, DJ | 1 |
| Blouin, LT | 1 |
| Safar, M | 3 |
| Baglin, A | 2 |
| Sobel, A | 2 |
| Merceron, R | 1 |
| Milliez, P | 3 |
| Davison, AM | 1 |
| Lambie, AT | 1 |
| Verth, AH | 1 |
| Cash, JD | 1 |
| Cantarovich, F | 1 |
| Benedetti, L | 1 |
| Fernández, JC | 1 |
| Chena, C | 1 |
| Castro, L | 1 |
| Galli, CJ | 1 |
| Pérez Loredo, J | 1 |
| Locatelli, A | 1 |
| Tizado, J | 1 |
| Marosi, J | 1 |
| Takó, J | 1 |
| Perez-Stable, EC | 1 |
| Materson, BJ | 1 |
| Wilson, JG | 1 |
| Maren, TH | 1 |
| Takano, K | 1 |
| Ellison, A | 1 |
| Wandrey, H | 1 |
| Sedlmeier, K | 1 |
| Zöllner, N | 1 |
| Eckert, RC | 1 |
| Gebott, MD | 1 |
| Harrington, AR | 1 |
| Willis, LR | 1 |
| Lynch, RE | 1 |
| Knox, FG | 1 |
| Ulvila, JM | 1 |
| Kennedy, JA | 1 |
| Lamberg, JD | 1 |
| Scribner, BH | 1 |
| Ragni, R | 1 |
| Segoloni, G | 1 |
| Piccoli, G | 1 |
| Weiner, MW | 1 |
| Weinman, EJ | 1 |
| Kashgarian, M | 1 |
| Hayslett, JP | 1 |
| Sutton, J | 1 |
| Aoki, VS | 1 |
| Robinson, SM | 1 |
| Sólomon-Santibañez, G | 1 |
| Vargas-Rosendo, R | 1 |
| Gunstone, RF | 1 |
| Wing, AJ | 1 |
| Shani, HG | 1 |
| Njemo, D | 1 |
| Sabuka, EM | 1 |
| Hutás, I | 1 |
| Gordon, RD | 1 |
| Pawsey, CG | 1 |
| O'Halloran, MW | 1 |
| Abbott, ML | 1 |
| Wilson, LL | 1 |
| Silverstone, H | 1 |
| Cruz, J | 1 |
| Mattar, E | 1 |
| Cruz, HM | 1 |
| Shapiro, S | 1 |
| Slone, D | 1 |
| Lewis, GP | 1 |
| Jick, H | 1 |
| Resano Pérez, FJ | 1 |
| Bravo Sandoval, J | 1 |
| Eknoyan, G | 1 |
| Martinez-Maldonado, M | 1 |
| Yium, JJ | 1 |
| Suki, WN | 1 |
| Jewkes, RF | 1 |
| Burki, N | 1 |
| Varriale, P | 1 |
| Tang, JV | 1 |
| Villanueva, F | 1 |
| Kessel, M | 1 |
| Nagel, A | 1 |
| Van der Horst, RL | 1 |
| Richardson, H | 1 |
| Steele, TH | 1 |
| Bayard, F | 1 |
| Alicandri, CL | 1 |
| Beitins, IZ | 1 |
| Lubash, GD | 1 |
| Kowarski, A | 1 |
| Migeon, CJ | 1 |
| Krecke, HJ | 1 |
| Timmler, R | 1 |
| Betzien, G | 1 |
| Nakano, S | 1 |
| Knott, DH | 1 |
| Beard, JD | 1 |
| Espiner, EA | 1 |
| Jagger, PI | 1 |
| Tucci, JR | 1 |
| Lauler, DP | 1 |
| Quellhorst, E | 1 |
| Scheler, F | 1 |
| Bergström, J | 1 |
| Hultman, E | 1 |
| Steigmann, F | 1 |
| Oz, R | 1 |
| Dubin, A | 1 |
| AbuHafsa, SH | 1 |
| Hassan, AA | 1 |
| Camacho, LM | 1 |
| Salem, AZ | 1 |
| Sharma, S | 1 |
| Sahu, D | 1 |
| Das, HR | 1 |
| Sharma, D | 1 |
| Han, LK | 1 |
| Sumiyoshi, M | 1 |
| Zhang, J | 1 |
| Liu, MX | 1 |
| Zhang, XF | 1 |
| Zheng, YN | 1 |
| Okuda, H | 1 |
| Kimura, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ultrafiltration for the Chronic Treatment of Severe Congestive Heart Failure[NCT00360958] | Phase 4 | 60 participants (Actual) | Interventional | 2006-08-31 | Completed | ||
| The Role of Vasopressin Antagonism on Renal Sodium Handling[NCT03910231] | Phase 1 | 30 participants (Actual) | Interventional | 2012-02-01 | Completed | ||
| Reliability and Utility of Fluid Balance Charting in Neonates Admitted to the Pediatric Ward.[NCT00962754] | Phase 4 | 170 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial[NCT03923933] | Phase 2 | 34 participants (Actual) | Interventional | 2019-06-18 | Completed | ||
| Urea for Chronic Hyponatremia: A Pilot Study[NCT04588207] | Phase 2 | 2 participants (Actual) | Interventional | 2021-12-28 | Terminated (stopped due to Unable to recruit participants) | ||
| Hypertonic Saline With Furosemide and a Normosodic Diet for the Treatment of Decompensated Congestive Heart Failure With Prerenal Physiology[NCT00575484] | Phase 2 | 11 participants (Actual) | Interventional | 2007-11-30 | Terminated | ||
| HSS (Hypertonic Saline Solution) Plus High Dose Furosemide vs High Dose Furosemide in Nephrotic Syndrome - a Randomized Trial[NCT03750136] | 30 participants (Anticipated) | Interventional | 2018-12-15 | Recruiting | |||
| Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing With Furosemide: a Pilot Study[NCT03746002] | Phase 4 | 3 participants (Actual) | Interventional | 2019-01-01 | Terminated (stopped due to Insufficient rate of patient enrollment/accrual.) | ||
| Fluid Balance During Exercise in the Heat With Water, Flavored Placebo, or a Carbohydrate-electrolyte Beverage Intake (The APEX Study)[NCT01893853] | 24 participants (Actual) | Interventional | 2012-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
notifications of complications (NCT00962754)
Timeframe: duration of admission
| Intervention | participants (Number) |
|---|---|
| Physician Insight Fluid Balance | 2 |
| Physician no Insight Fluid Balance Chart | 5 |
Duration of hospital stay in days or duration of admission at the pediatric ward in days (NCT00962754)
Timeframe: 1-8 months
| Intervention | number of days (Median) |
|---|---|
| Intervention Group (no Insight in Fluid Balance) | 9 |
| Control Group (Insight in Fluid Balance) | 8 |
prescription of diuretic therapy (NCT00962754)
Timeframe: during days of admission
| Intervention | participants (Number) |
|---|---|
| Intervention Group (no Insight in Fluid Balance) | 0 |
| Control Group (Insight in Fluid Balance) | 0 |
(NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | mmHg (Mean) |
|---|---|
| Placebo | -3.4 |
| Treatment Grup | -13.5 |
Decrease in extracellular water measured by bioelectrical impedance analysis (NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | litres (Mean) |
|---|---|
| Placebo | -0.15 |
| Treatment Grup | 2.55 |
Decrease in extracellular water / total body water ratio measured by bioelectrical impedance analysis (NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | percentage of ECW/TBW (Mean) |
|---|---|
| Placebo | -0.24 |
| Treatment Grup | -2.92 |
decrease in blood pressure compared wit baseline measure (mmhg) (NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | mmHg (Mean) |
|---|---|
| Placebo | -5.4 |
| Treatment Grup | -18.1 |
(NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | mmHg (Mean) |
|---|---|
| Placebo | -10 |
| Treatment Grup | -26.1 |
Increase in the fractional excretion of sodium compared with the baseline measure (NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | percentage of sodium excreted (Mean) |
|---|---|
| Placebo | -0.348 |
| Treatment Grup | 0.598 |
Measured by bioelectrical impedance analysis, compared to the initial measurement (NCT03923933)
Timeframe: Change from Basal to day 28
| Intervention | litres (Mean) |
|---|---|
| Placebo | -0.075 |
| Treatment Grup | -4.36 |
Total measured urine output in milliliters produced after metolazone dose is given (NCT03746002)
Timeframe: 24 hours
| Intervention | mL (Mean) |
|---|---|
| Metolazone Concurrent Dosing | 2030 |
| Metolazone Pre-dosing | 5650 |
Portion of patients with increase in serum creatinine by ≥ 0.3 mg/dL or ≥ 50% from baseline (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 1 |
| Metolazone Pre-dosing | 1 |
Change in serum creatinine from baseline value collected prior to metolazone dose to value collected after metolazone dose (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | mg/dL (Mean) |
|---|---|
| Metolazone Concurrent Dosing | 0.45 |
| Metolazone Pre-dosing | 0.38 |
Change in total body weight from baseline value measured prior to metolazone dose to value collected after metolazone dose (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | kg (Mean) |
|---|---|
| Metolazone Concurrent Dosing | -.6 |
| Metolazone Pre-dosing | -8.5 |
Proportion of patients with potassium level less than 4.0 mEq/L measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 1 |
Proportion of patients with magnesium level less than 2.0 mg/dL measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 1 |
Proportion of patients with serum sodium level less than 135 mg/dL measured after metolazone dose is given (NCT03746002)
Timeframe: Baseline and at 12 to 23 hours after metolazone dose
| Intervention | Participants (Count of Participants) |
|---|---|
| Metolazone Concurrent Dosing | 0 |
| Metolazone Pre-dosing | 0 |
3 reviews available for furosemide and Body Weight
| Article | Year |
|---|---|
Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Topics: Body Weight; Diuresis; Diuretics; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidn | 2021 |
Clinical aspects and pathophysiology of diuretic-induced hyponatremia.
Topics: Age Factors; Aged; Benzothiadiazines; Body Water; Body Weight; Diuretics; Female; Furosemide; Humans | 1984 |
Diuretic drug therapy of edema.
Topics: Ambulatory Care; Ascites; Body Weight; Chlorides; Diuresis; Diuretics; Edema; Ethacrynic Acid; Furos | 1971 |
64 trials available for furosemide and Body Weight
| Article | Year |
|---|---|
Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Body Weight; Diuretics; Drug Therapy, Combi | 2019 |
Differences in pharmacological property between combined therapy of the vasopressin V2-receptor antagonist tolvaptan plus furosemide and monotherapy of furosemide in patients with hospitalized heart failure.
Topics: Aged; Aged, 80 and over; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Blood Press | 2020 |
Effect of furosemide on body composition and urinary proteins that mediate tubular sodium and sodium transport-A randomized controlled trial.
Topics: Adult; Body Composition; Body Weight; Dielectric Spectroscopy; Diuretics; Female; Furosemide; Humans | 2021 |
Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weig | 2017 |
Effects of furosemide administration to water-deprived inland bearded dragons (Pogona vitticeps).
Topics: Animals; Body Composition; Body Weight; Cross-Over Studies; Diuretics; Furosemide; Lizards; Male; Wa | 2018 |
Furosemide Dose Changes Associated with Furosemide/Tolvaptan Combination Therapy in Patients with Cirrhosis.
Topics: Aged; Aged, 80 and over; Ascites; Body Weight; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2020 |
Continuous ultrafiltration for congestive heart failure: the CUORE trial.
Topics: Aged; Aged, 80 and over; Body Weight; Cardiovascular Agents; Confidence Intervals; Diuretics; Dose-R | 2014 |
Effects of short-term administration of tolvaptan after open heart surgery.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Cardiac Surgical Procedu | 2016 |
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Ascites; Body Weight; Diuretics; Double-Blind Metho | 2010 |
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weight; | 2010 |
Effects of tolvaptan on volume overload in Japanese patients with heart failure: results of a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body Weight; Diu | 2011 |
Phase III clinical pharmacology study of tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body | 2011 |
A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Weight; Diuretics; Double-Blind Method | 2011 |
Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressu | 2003 |
Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Diuretics; Female; | 2003 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arg | 2003 |
Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
Topics: Adult; Aged; Aquaporin 2; Aquaporins; Body Weight; Felodipine; Female; Furosemide; Health; Humans; M | 2005 |
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Bumetanide; Diuretics; Drug Therapy, Combinati | 2005 |
Effects of specific COX-2-inhibition on renin release and renal and systemic prostanoid synthesis in healthy volunteers.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Body Weight; Celecoxib; Creatinine; Cross-Over Stu | 2005 |
Studies on furosemide: an effective oral saludiuretic for bilharzial ascites.
Topics: Adolescent; Adult; Ascites; Body Weight; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle A | 1967 |
Frusemide/amiloride combination ('Frumil') in heart failure: an open, multi-centre study in general practice.
Topics: Aged; Amiloride; Body Weight; Clinical Trials as Topic; Drug Combinations; Edema; Female; Furosemide | 1984 |
Sodium sensitivity in essential hypertension: role of the renin-angiotensin-aldosterone system and predictive value of an intravenous frusemide test.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Diet; Female; Furosemide; Humans; Hypertension; Mal | 1984 |
A comparison of the effect of combined frusemide and controlled-release potassium tablets (Diumide-K continus tablets) and frusemide and slow-K tablets in elderly patients with cardiac failure.
Topics: Aged; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Th | 1982 |
Treatment of nephrotic edema with bumetanide.
Topics: Adolescent; Adult; Aged; Body Weight; Bumetanide; Clinical Trials as Topic; Diuretics; Edema; Female | 1981 |
Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Topics: Ascites; Body Weight; Clinical Trials as Topic; Drug Therapy, Combination; Female; Furosemide; Hepat | 1981 |
Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia.
Topics: Adult; Body Weight; Clinical Trials as Topic; Diuretics; Drug Combinations; Female; Furosemide; Huma | 1982 |
Controlled comparison of the effects of furosemide and hydrochlorothiazide added to propranolol in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Therapy, Combination; Female; Furosemide; Heart Rate; | 1981 |
Spironolactone and enzyme induction in patients with alcoholic cirrhosis.
Topics: Adult; Aged; Antipyrine; Body Weight; Drug Interactions; Enzyme Induction; Female; Furosemide; Human | 1980 |
Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
Topics: Aged; Analysis of Variance; Body Weight; Cross-Over Studies; Double-Blind Method; Female; Furosemide | 1995 |
Nebulized furosemide in infants with bronchopulmonary dysplasia.
Topics: Airway Resistance; Body Weight; Bronchopulmonary Dysplasia; Dose-Response Relationship, Drug; Female | 1994 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
Torasemide in the treatment of patients with cirrhosis and ascites.
Topics: Adult; Aged; Ascites; Body Weight; Canrenoic Acid; Combined Modality Therapy; Diet, Sodium-Restricte | 1993 |
Validation of multifrequency bioelectrical impedance analysis in monitoring fluid balance in healthy elderly subjects.
Topics: Aged; Aging; Body Fluids; Body Water; Body Weight; Diuretics; Electric Impedance; Evaluation Studies | 1997 |
Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Topics: Body Weight; Cyclooxygenase Inhibitors; Diuretics; Ductus Arteriosus, Patent; Female; Furosemide; Ge | 1997 |
Patterns of potassium wasting in response to stepwise combinations of diuretics in nephrotic syndrome.
Topics: Aged; Amiloride; Body Weight; Chlorthalidone; Diuresis; Diuretics; Drug Therapy, Combination; Female | 1999 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Weight; Creatinine; Diuresis; Diuretics; Drug Therapy, | 2000 |
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Diuresis; Diuretics; Female; Furosemide; Humans; Kidney | 2001 |
Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Cycloox | 1979 |
An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Topics: Ascites; Body Weight; Clinical Trials as Topic; Diuretics; Furosemide; Humans; Liver Cirrhosis; Plas | 1977 |
Sodium intake and furosemide administration in hypertensive patients with renal insufficiency.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Diet; Diet, Sodium-Restricted; Drug In | 1977 |
Diuretic therapies in low renin and normal renin essential hypertension.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Double-Blind Method; Drug Combinations | 1977 |
Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Furosemide; Humans; Hydrochlorothiazide; Hype | 1978 |
[Studies on the diuretic effects of etozolin (Elkapin) in heart failure - a comparison with the loop diuretic agent furosemide (author's transl)].
Topics: Blood Cell Count; Blood Pressure; Body Weight; Diuretics; Electrolytes; Furosemide; Heart Failure; H | 1979 |
Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.
Topics: Adult; Bicarbonates; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuresis; Dose-Response | 1975 |
A double-blind study in hypertensive patients of an original new compound, indapamide.
Topics: Adult; Antihypertensive Agents; Benzamides; Blood Pressure Determination; Blood Proteins; Blood Urea | 1975 |
Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Bromine; Chlorthalidone; Clinical Trials as Topic; Diet, S | 1975 |
Effects of large doses of furosemide in end-stage chronic renal failure.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Female; Furosemide; Glomeruloneph | 1975 |
Chronotherapeutic study of furosemide in hypertensive subjects: a preliminary report.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Weight; Drug Administration Schedule; Electrolytes; | 1991 |
Mechanism of impaired natriuretic response to furosemide during prolonged therapy.
Topics: Adult; Aged; Aldosterone; Body Weight; Chlorothiazide; Furosemide; Humans; Hypertension; Male; Middl | 1989 |
Prophylactic furosemide in severe respiratory distress syndrome: blinded prospective study.
Topics: Body Weight; Furosemide; Humans; Infant, Newborn; Plasma Volume; Pulse; Random Allocation; Respirati | 1988 |
Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver.
Topics: Administration, Oral; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Double-Blind Metho | 1988 |
Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
Topics: Aged; Aged, 80 and over; Blood Pressure; Blood Urea Nitrogen; Body Weight; Clinical Trials as Topic; | 1988 |
Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Bl | 1988 |
Effects of low-dose aspirin on responses to furosemide.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Body Weight; Eicosanoic Acids; Electr | 1986 |
Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
Topics: Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Creatinine; Diuretics; Double-Blind | 1986 |
Mechanism of increased plasma urea after diuretic therapy in uraemic patients.
Topics: Body Weight; Furosemide; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Tubules | 1985 |
Renal response to frusemide in preterm infants with respiratory distress syndrome during the first three postnatal days.
Topics: Apgar Score; Blood Urea Nitrogen; Body Weight; Calcium; Creatinine; Electrolytes; Furosemide; Glomer | 1985 |
Effect of diuretic therapy on glucose tolerance in hypertensive patients.
Topics: Age Factors; Blood Glucose; Body Weight; Diabetes Mellitus; Diuretics; Ethacrynic Acid; Fasting; Fat | 1971 |
Spironolactone and frusemide in cirrhosis with ascites.
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Diuresis; Drug Synergism; Female; Furosemi | 1973 |
Xipamid in the treatment of oedema in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Body Weight; Clinical Trials as Topic; Diuretics; Edema; Female; Furose | 1974 |
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
Topics: Adult; Aged; Body Weight; Chlorides; Clinical Trials as Topic; Clopamide; Creatinine; Diet, Sodium-R | 1970 |
[Efficacy of intravenous furosemide in the initial stage of poststreptococcal acute glomerulonephritis].
Topics: Acute Disease; Adolescent; Blood Pressure; Body Weight; Child; Child, Preschool; Clinical Trials as | 1971 |
The effect of thiazides, chlorthalidone and furosemide on muscle electrolytes and muscle glycogen in normal subjects.
Topics: Body Weight; Chlorthalidone; Diuresis; Diuretics; Furosemide; Glycogen; Humans; Muscles; Water-Elect | 1966 |
Replacement of berseem hay by Salix tetrasperma on physiological performance of New Zealand White rabbits under subtropical conditions of Egypt.
Topics: Alanine Transaminase; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Aspartate Am | 2014 |
232 other studies available for furosemide and Body Weight
| Article | Year |
|---|---|
Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Body Weig | 2017 |
Comparison of cochlear cell death caused by cisplatin, alone and in combination with furosemide.
Topics: Analysis of Variance; Animals; Body Weight; Cisplatin; Cochlea; Evoked Potentials, Auditory, Brain S | 2014 |
Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
Topics: Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Length of Stay; Male; Middl | 2013 |
Perinatal growth restriction decreases diuretic action of furosemide in adult rats.
Topics: Animals; Blood Proteins; Body Weight; Diet, Protein-Restricted; Diuretics; Female; Fetal Growth Reta | 2014 |
Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
Topics: Animals; Blood Glucose; Body Weight; Diabetic Nephropathies; Disease Models, Animal; Diuretics; Echo | 2014 |
Furosemide Pharmacokinetics in Adult Rats become Abnormal with an Adverse Intrauterine Environment and Modulated by a Post-Weaning High-Fat Diet.
Topics: Animals; Body Composition; Body Weight; Diet, High-Fat; Diet, Protein-Restricted; Female; Fetal Grow | 2016 |
Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Body W | 2015 |
The Effects of Early Postnatal Diuretics Treatment on Kidney Development and Long-Term Kidney Function in Wistar Rats.
Topics: Acute-Phase Proteins; Aging; Animals; Apoptosis; Blood Pressure; Body Weight; Cell Proliferation; Di | 2016 |
Early oxytocin inhibition of salt intake after furosemide treatment in rats?
Topics: Analysis of Variance; Animals; Body Weight; Contraceptive Agents; Drinking; Estradiol; Female; Furos | 2017 |
[Functional MR urography in children].
Topics: Adult; Age Factors; Body Weight; Child, Preschool; Contrast Media; Diuretics; Female; Furosemide; Ga | 2009 |
Lateral parabrachial nucleus and central amygdala in the control of sodium intake.
Topics: Adrenergic Antagonists; Amygdala; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Ca | 2010 |
Diuretic treatment affects the length of torpor bouts in hibernating European ground squirrels (Spermophilus citellus).
Topics: Animals; Arousal; Body Temperature; Body Weight; Diuresis; Diuretics; Europe; Furosemide; Hibernatio | 2010 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; | 2011 |
Involvement of brain ANG II in acute sodium depletion induced salty taste changes.
Topics: Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Appet | 2012 |
Thirst and salt appetite responses in young and old Brown Norway rats.
Topics: Aging; Animals; Antihypertensive Agents; Appetite; Body Fluids; Body Weight; Captopril; Drinking Beh | 2003 |
Effect of frusemide on bodyweight loss and recovery in racing Standardbreds.
Topics: Acid-Base Equilibrium; Animals; Body Weight; Dehydration; Diuretics; Female; Furosemide; Horse Disea | 2002 |
Salt appetite of adrenalectomized rats after a lesion of the SFO.
Topics: Adrenalectomy; Angiotensin II; Animals; Appetite; Body Weight; Diuretics; Drinking; Furosemide; Male | 2002 |
Furosemide, sodium appetite, and ingestive behavior.
Topics: Animals; Appetite; Body Weight; Diuretics; Dose-Response Relationship, Drug; Drinking; Eating; Food | 2003 |
Monitoring hyperhydration during high-dose chemotherapy: body weight or fluid balance?
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Body Water; Body Weight; Cohort Studies; Confounding | 2003 |
Effect of the diuretic furosemide on urinary essential nutrient loss and on body stores in growing rats.
Topics: Absorption; Animals; Body Composition; Body Weight; Diuretics; Eating; Electrolytes; Female; Furosem | 2005 |
Investigation of aldosterone-synthase inhibition in rats.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP11B2; Diuretics; Dose-Respons | 2006 |
Sequential expression of NKCC2, TonEBP, aldose reductase, and urea transporter-A in developing mouse kidney.
Topics: Aldehyde Reductase; Animals; Animals, Newborn; Body Weight; Diuretics; Furosemide; Immunohistochemis | 2007 |
Frusemide results in an extracellular to intracellular fluid shift in horses.
Topics: Animals; Body Fluid Compartments; Body Water; Body Weight; Diuretics; Dose-Response Relationship, Dr | 2006 |
Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Dru | 2007 |
Effects of oral administration of furosemide and torsemide in healthy dogs.
Topics: Administration, Oral; Animals; Blood Proteins; Blood Urea Nitrogen; Body Weight; Creatinine; Diureti | 2007 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; | 2008 |
Aging, circadian weight change, and nocturia.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Bed Rest; Body Weight; Circadian Rhythm; Diureti | 2008 |
[Saluretics in the treatment of cardiac and renal edema].
Topics: Blood Circulation; Body Weight; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1966 |
Furosemide, a new diuretic in edematous states. Clinical studies in patients with congestive heart failure and cirrhosis of the liver.
Topics: Aged; Body Weight; Edema; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Injections, Intrav | 1967 |
Ethacrynic acid: assessment of saluretic and diuretic potency in patients with severe chronic renal failure.
Topics: Adult; Aged; Bendroflumethiazide; Blood Urea Nitrogen; Body Weight; Chlorides; Creatine; Diuretics; | 1967 |
Antihypertensive properties of furosemide.
Topics: Alkaline Phosphatase; Blood Proteins; Blood Urea Nitrogen; Blood Volume; Body Weight; Electrolytes; | 1967 |
Long-term treatment with minoxidil in patients with severe renal failure.
Topics: Acute Kidney Injury; Adult; Body Weight; Female; Furosemide; Humans; Hypertension; Hypertension, Pul | 1980 |
Rapid reduction of severe hypertension with minoxidil.
Topics: Adult; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynami | 1980 |
Changes in oncotic pressure, osmolality and electrolytes following transurethral resection of the prostate using glycine as irrigating solution.
Topics: Aged; Body Weight; Furosemide; Glycine; Humans; Male; Osmolar Concentration; Osmotic Pressure; Posto | 1983 |
Clinical syndromes associated with disorders of renal tubular chloride transport: excess and deficiency of a circulating factor?
Topics: Aldosterone; Angiotensin II; Bartter Syndrome; Body Weight; Chlorides; Female; Furosemide; Humans; H | 1984 |
[Effect of azosemide (SK-110) and its metabolites on mouse liver].
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Carbo | 1984 |
Differential effects of sauna-, diuretic-, and exercise-induced hypohydration.
Topics: Adult; Blood Volume; Body Weight; Furosemide; Humans; Lactates; Lactic Acid; Male; Oxygen; Physical | 1984 |
The pharmacokinetics of frusemide are influenced by age.
Topics: Adult; Aged; Aging; Body Weight; Creatinine; Furosemide; Humans; Kinetics; Male; Middle Aged; Protei | 1983 |
Efficacy of two proprietary preparations of frusemide in patients with congestive heart failure.
Topics: Biological Availability; Body Weight; Double-Blind Method; Drug Evaluation; Furosemide; Heart Failur | 1984 |
Decreased ultrafiltration coefficient of glomeruli isolated from volume-depleted rats.
Topics: Animals; Blood Proteins; Body Weight; Creatinine; Dehydration; Female; Furosemide; Glomerular Filtra | 1984 |
Effect of diuretics on the tubuloglomerular feedback response.
Topics: Animals; Body Weight; Bumetanide; Diuretics; Feedback; Furosemide; Hydrochlorothiazide; Kidney Glome | 1984 |
Restoration of ultrafiltration capacity of peritoneal membrane in patients on CAPD.
Topics: Body Weight; Female; Furosemide; Humans; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous | 1984 |
Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
Topics: Adolescent; Adult; Aged; Body Weight; Chlorides; Creatinine; Edema; Female; Furosemide; Humans; Hype | 1981 |
The occurrence of hyperaldosteronism in infants with congestive heart failure.
Topics: Aldosterone; Body Weight; Epidemiologic Methods; Furosemide; Heart Failure; Humans; Hyperaldosteroni | 1980 |
The effect of prostaglandin inhibition on renin release. A comparison of furosemide and low-sodium stimulation tests.
Topics: Adult; Body Weight; Diet, Sodium-Restricted; Female; Furosemide; Humans; Indomethacin; Male; Posture | 1981 |
Renin response to furosemide differs with the routes of administration in health men.
Topics: Administration, Oral; Adult; Blood Pressure; Body Weight; Furosemide; Heart Rate; Hematocrit; Humans | 1982 |
The fate of phenobarbitone in children in hypothermia and at normal body temperature.
Topics: Adolescent; Age Factors; Body Temperature; Body Weight; Child; Child, Preschool; Furosemide; Glucuro | 1982 |
Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Drug Combinations; Female; Furosemide; Heart Rate; Humans; | 1982 |
Comparative antihypertensive effects of a diuretic, reserpine, and hydralazine in the spontaneously hypertensive rat.
Topics: Animals; Body Weight; Disease Models, Animal; Female; Furosemide; Hydralazine; Hypertension; Intesti | 1981 |
Furosemide-induced hyperuricemia, hyperglycemia, hypertension and arterial lesions in nonarteriosclerotic and arteriosclerotic rats.
Topics: Animals; Arteries; Arteriosclerosis; Blood Glucose; Blood Pressure; Body Weight; Corticosterone; Cre | 1981 |
[Furosemide and metolazone: a highly effective diuretic combination].
Topics: Ascites; Body Weight; Diuresis; Diuretics; Drug Combinations; Edema, Cardiac; Female; Furosemide; He | 1980 |
Antagonism of frusemide diuresis by diphenylhydantoin sodium.
Topics: Animals; Body Weight; Diuresis; Furosemide; Male; Phenytoin; Rats; Rats, Inbred Strains | 1981 |
On the clinical usefulness of the FENa test in acute renal failure: a critical analysis.
Topics: Acute Kidney Injury; Adult; Aged; Blood Pressure; Body Weight; Creatinine; Diagnosis, Differential; | 1980 |
[Therapy of gestoses].
Topics: Antihypertensive Agents; Body Weight; Diet, Sodium-Restricted; Eclampsia; Female; Furosemide; Humans | 1980 |
Low salt diet and frusemide in the treatment of hypertension.
Topics: Blood Pressure; Body Weight; Diet, Sodium-Restricted; Drug Administration Schedule; Female; Furosemi | 1980 |
Treatment of dilutional hyponatremia in congestive heart failure.
Topics: Adult; Aged; Body Weight; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Infusi | 1980 |
Diuretic treatment of resistant hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Body Weight; Cyclopenthiazide; Drug Resistance; Female; Furosemide | 1980 |
Water deprivation in lactating rats: changes in nucleolar dry mass of paraventricular and supraoptic neurones.
Topics: Animals; Body Weight; Cell Nucleolus; DNA; Female; Furosemide; Hypothalamus; Lactation; Neurons; Par | 1980 |
Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide.
Topics: Aged; Body Weight; Furosemide; Humans; Inappropriate ADH Syndrome; Male | 1981 |
Ascites free-water dynamics in decompensated cirrhosis: effects of acute and chronic frusemide treatment.
Topics: Abdomen; Administration, Oral; Adult; Aged; Aged, 80 and over; Ascites; Body Water; Body Weight; Fem | 1995 |
Changes of vascular architecture independent of blood pressure in experimental uremia.
Topics: Animals; Aorta, Abdominal; Blood Pressure; Blood Vessels; Body Weight; Capillaries; Furosemide; Hydr | 1995 |
A micropuncture study of renal tubular lithium reabsorption in sodium-depleted rats.
Topics: Absorption; Amiloride; Animals; Body Weight; Furosemide; Kidney Tubules; Kidney Tubules, Collecting; | 1995 |
Furosemide reduces the incidence of pulmonary hypertension syndrome (ascites) in broilers exposed to cool environmental temperatures.
Topics: Animals; Body Weight; Chickens; Cold Temperature; Furosemide; Hypertension, Pulmonary; Incidence; Ma | 1995 |
Endocrine changes associated with a rapidly developing sodium appetite in rats.
Topics: Aldosterone; Angiotensin I; Animals; Appetite; Body Weight; Captopril; Diuresis; Dose-Response Relat | 1994 |
Thromboxane A2-prostaglandin H2 and renovascular hypertension in rats.
Topics: Aging; Angiotensin II; Animals; Arginine Vasopressin; Baroreflex; Blood Pressure; Body Weight; Capry | 1994 |
Renin-angiotensin, arterial blood pressure, and salt appetite in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Appetite; Biphenyl Compounds; Bl | 1994 |
Differential changes in central monoaminergic metabolism during first and multiple sodium depletions in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain Chemistry; Chromato | 1994 |
Effects of sodium bicarbonate and ammonium chloride on the incidence of furosemide-induced fetal skeletal anomaly, wavy rib, in rats.
Topics: Alkalosis; Ammonium Chloride; Animals; Body Weight; Drug Interactions; Female; Furosemide; Male; Pre | 1993 |
Effects of dehydration on thermoregulatory responses of horses during low-intensity exercise.
Topics: Animals; Body Temperature Regulation; Body Weight; Cardiac Output; Dehydration; Female; Furosemide; | 1993 |
Furosemide stimulates renin expression in the kidneys of salt-supplemented rats.
Topics: Animals; Body Weight; Furosemide; Kidney; Loop of Henle; Male; Rats; Rats, Wistar; Renin; Sodium Chl | 1993 |
Opioidergic manipulations affect intake of 3% NaCl in sodium-deficient rats.
Topics: Animals; Body Weight; Drinking Behavior; Furosemide; Male; Morphine; Naltrexone; Narcotics; Rats; Ra | 1993 |
Infraadditive diuretic efficacy of concurrent aminophylline and frusemide.
Topics: Aminophylline; Animals; Body Weight; Diuretics; Drug Interactions; Furosemide; Male; Rats | 1993 |
Effects of furosemide on renal oxygen consumption after ischemia in normal and streptozotocin diabetic rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Furosemide; Ischemia; Kidney; Kidney Cortex; | 1993 |
Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition.
Topics: Administration, Oral; Animals; Blood Proteins; Body Weight; Dietary Proteins; Furosemide; Gastric Mu | 1993 |
Bioelectrical impedance analysis as an assessment of diuresis in congestive heart failure.
Topics: Administration, Oral; Aged; Body Composition; Body Water; Body Weight; Cohort Studies; Diuretics; El | 1995 |
Beneficial effect of amiloride, A Na(+)-H+ exchange blocker, in a murine model of dilated cardiomyopathy.
Topics: Amiloride; Angiotensin II; Animals; Body Weight; Cardiomyopathy, Dilated; Disease Models, Animal; Di | 1996 |
Sodium depletion and maternal separation in the suckling rat increase its salt intake when adult.
Topics: Aldosterone; Animals; Animals, Suckling; Anxiety, Separation; Body Weight; Diuretics; Drinking Behav | 1996 |
Effects of furosemide, torasemide and controlled fluid intake on perfluoroisobutene induced lung oedema and mortality.
Topics: Animals; Body Weight; Diuretics; Drinking; Female; Fluorocarbons; Furosemide; Hematocrit; Lung; Myoc | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Diuretics; Electrolytes; Furosemide; G | 1996 |
Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats.
Topics: Animals; Antihypertensive Agents; Body Weight; Disease Models, Animal; Drinking Behavior; Furosemide | 1997 |
Effect of sympathetic and angiotensin-aldosterone systems on renal salt conservation in the rat.
Topics: Adrenalectomy; Aldosterone; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biph | 1997 |
Fluid administration attenuates the haemodynamic effect of frusemide in running horses.
Topics: Animals; Atrial Function, Right; Atrial Natriuretic Factor; Blood Proteins; Blood Volume; Body Weigh | 1998 |
Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy.
Topics: Animals; Blotting, Northern; Body Weight; Diuretics; Furosemide; Hypertension, Pulmonary; Hypertroph | 1998 |
A reliable, practical, and economical protocol for inducing diarrhea and severe dehydration in the neonatal calf.
Topics: Animals; Animals, Newborn; Blood Glucose; Blood Proteins; Body Temperature; Body Weight; Cattle; Col | 1998 |
Chronic administration of furosemide augments renal weight and glomerular capillary pressure in normal rats.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Body Weight; Capillaries; Furosemide; Glo | 1998 |
The area postrema does not modulate the long-term salt sensitivity of arterial pressure.
Topics: Animals; Blood Pressure; Body Weight; Cerebral Ventricles; Energy Intake; Furosemide; Heart Rate; Ho | 1998 |
Drinking and blood pressure during sodium depletion or ANG II infusion in chronic cholestatic rats.
Topics: Angiotensin II; Animals; Appetite; Blood Pressure; Body Weight; Cholestasis; Chronic Disease; Common | 1999 |
Effects of chronic octreotide treatment on renal changes during cirrhosis in rats.
Topics: Animals; Body Water; Body Weight; Delayed-Action Preparations; Electrolytes; Female; Furosemide; Hem | 1999 |
Effect of thiazide on established furosemide-induced nephrocalcinosis in the young rat.
Topics: Animals; Body Weight; Calcium; Chlorothiazide; Creatinine; Diuretics; Furosemide; Kidney; Male; Neph | 2000 |
Preservation of the right atrial appendage improves reduced plasma atrial natriuretic peptide levels after the maze procedure.
Topics: Atrial Appendage; Atrial Fibrillation; Atrial Natriuretic Factor; Body Weight; Cardiac Surgical Proc | 2000 |
Effects of fluid management on edema volume and midline shift in a rat model of ischemic stroke.
Topics: Animals; Body Weight; Brain Edema; Brain Ischemia; Cerebral Cortex; Dehydration; Disease Models, Ani | 2000 |
Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Synergism; Furosemide; Ki | 2000 |
Relationships with serum parathyroid hormone in old institutionalized subjects.
Topics: Aged; Aged, 80 and over; Benzothiadiazines; Body Weight; Cross-Sectional Studies; Diuretics; Female; | 2001 |
Efficacy of nasal strip and furosemide in mitigating EIPH in Thoroughbred horses.
Topics: Animals; Blood Pressure; Body Weight; Bronchoalveolar Lavage Fluid; Diuretics; Esophagus; Furosemide | 2001 |
Effects of an external nasal strip and frusemide on pulmonary haemorrhage in Thoroughbreds following high-intensity exercise.
Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; Carbon Dioxide; Combined Modality Therapy; Diure | 2001 |
Spontaneous renal blood flow autoregulation curves in conscious sinoaortic baroreceptor-denervated rats.
Topics: Animals; Aorta; Blood Pressure; Body Weight; Consciousness; Denervation; Diuretics; Furosemide; Home | 2002 |
[Treatment of severe hypertension with minoxidil combined with beta-blocking agents and diuretics].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; | 1975 |
Effect of chronic furosemide administration on hydrogen and sodium excretion in the dog.
Topics: Acid-Base Equilibrium; Adrenalectomy; Animals; Bicarbonates; Body Weight; Chlorides; Diet; Dogs; Dru | 1977 |
Diuretic-induced oedema.
Topics: Adult; Aldosterone; Blood Volume; Body Weight; Chlorthalidone; Diuretics; Edema; Female; Furosemide; | 1975 |
Biochemical correlates of the increase in blood pressure with age.
Topics: Aging; Aldosterone; Black People; Blood Pressure; Body Weight; Furosemide; Humans; Norepinephrine; R | 1978 |
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Body Weight; Budd-Chiari Syndrome; Cardiac Output; Diuresis; Drai | 1979 |
Effect of furosemide on experimental traumatic cerebral edema.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Brain; Brain Edema; Cats; Contusions; Craniocerebral Trau | 1979 |
[Therapy of cardiac edema using Lasix long 30].
Topics: Body Weight; Delayed-Action Preparations; Furosemide; Heart Failure; Hemodynamics; Humans | 1979 |
Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Body Weight; Creatinine; Electrolytes; Female; Furosemide; | 1979 |
Individual renin-aldosterone responses of clinically healthy young Japanese men to dietary sodium and posture.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Aldosterone; Body Weight; Creatinine; Diet, Sodiu | 1979 |
Renin response to upright posture in varying sodium balance in normal young Japanese men.
Topics: Adult; Body Weight; Diet, Sodium-Restricted; Furosemide; Hematocrit; Humans; Male; Posture; Pulse; R | 1979 |
Duration of effect of different diuretics.
Topics: Aged; Biological Availability; Blood Pressure; Body Weight; Chlorothiazide; Chlorthalidone; Female; | 1979 |
Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics.
Topics: Aminoglycosides; Animals; Body Fluids; Body Weight; Cochlea; Drug Synergism; Furosemide; Gentamicins | 1978 |
[The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)].
Topics: Adolescent; Albumins; Body Weight; Child; Child, Preschool; Diet, Sodium-Restricted; Diuresis; Drug | 1977 |
Response of plasma aldosterone to orthostatism during follicular and luteal phases of the normal menstrual cycle.
Topics: Adult; Aldosterone; Body Weight; Diet, Sodium-Restricted; Female; Follicular Phase; Furosemide; Huma | 1977 |
[Physiopathological concepts on eclampsia (author's transl)].
Topics: Body Weight; Cesarean Section; Diazepam; Diet, Sodium-Restricted; Female; Furosemide; Humans; Hypert | 1978 |
The use of furosemide in the treatment of edema in infants and children.
Topics: Administration, Oral; Adolescent; Body Weight; Edema; Furosemide; Heart Diseases; Humans; Infusions, | 1978 |
The clinical value of digoxin in patients with heart failure and sinus rhythm.
Topics: Adult; Aged; Arrhythmia, Sinus; Body Water; Body Weight; Digoxin; Drug Therapy, Combination; Exercis | 1978 |
[Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
Topics: Animals; Blood Pressure; Body Weight; Canrenoic Acid; Furosemide; Hypertension; Male; Models, Biolog | 1976 |
A role of frusemide in resistant hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Benzothiadiazines; Blood Pressure; Body Weight; Diuretics; Dru | 1977 |
Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Creatinine; Diuret | 1977 |
Negative effect of frusemide pretreatment in glycerol induced acute renal failure.
Topics: Acute Kidney Injury; Animals; Blood Volume; Body Weight; Creatinine; Drinking; Drug Evaluation; Eati | 1977 |
An attempt to prevent spontaneous hypertension in rats by antihypertensive drug treatment.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Drug Therapy, Combination; Furosemide | 1977 |
Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Furo | 1977 |
Letter: Furosemide abuse without apparent adverse effect.
Topics: Adolescent; Body Weight; Female; Furosemide; Humans; Obsessive-Compulsive Disorder; Substance-Relate | 1976 |
Reduction of folic acid-induced acute tubular injury by diuresis: an experimental model.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Body Weight; Disease Models, Animal; Diuresis; DN | 1976 |
Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin suppression.
Topics: Acetazolamide; Acute Kidney Injury; Animals; Body Weight; Desoxycorticosterone; Diuresis; Furosemide | 1976 |
Diuretics in malignant effusions and edemas of generalized cancer.
Topics: Ascites; Body Weight; Bumetanide; Diuretics; Drinking; Edema; Furosemide; Humans; Neoplasms; Pleuris | 1976 |
Suppressed plasma renin activity in adrenal regeneration hypertension.
Topics: Adrenal Glands; Animals; Body Weight; Diuresis; Female; Furosemide; Hematocrit; Hypertension; Kidney | 1975 |
Diuretic agents and glucose reabsorption.
Topics: Absorption; Acetazolamide; Animals; Body Weight; Chlorothiazide; Diuretics; Dogs; Ethacrynic Acid; F | 1975 |
[Effect of furosemide on the urinary excretion of sodium in uremic children under hemodialysis].
Topics: Adolescent; Age Factors; Blood Pressure; Body Weight; Child; Drug Evaluation; Female; Furosemide; Hu | 1975 |
Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Furosemide; Humans; Hydralazine; Hypert | 1975 |
[Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
Topics: Aldosterone; Antihypertensive Agents; Blood Pressure; Body Weight; Butanes; Female; Furosemide; Huma | 1975 |
[Studies on the renin-angiotensin system in adrenal regeneration hypertension (author's transl)].
Topics: Adrenal Glands; Adrenal Medulla; Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Body Weig | 1975 |
[Animal experiments on the "dysionic genesis of intrauterine malformations"].
Topics: Abnormalities, Drug-Induced; Animals; Body Weight; Calcium; Female; Fetal Death; Fetus; Furosemide; | 1975 |
Effects of isradipine on plasma renin activity in sodium-loaded and -depleted conscious rabbits.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel | 1992 |
Influence of furosemide on hemodynamic responses during exercise in horses.
Topics: Animals; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Exercise Test; Furosemide; H | 1992 |
Influence of chronic lithium treatment on urinary amount of furosemide in rats.
Topics: Administration, Oral; Animals; Body Weight; Chlorides; Drinking; Furosemide; Lithium; Lithium Chlori | 1991 |
Furosemide kinetics and dynamics in rats and humans.
Topics: Animals; Body Weight; Diuresis; Female; Furosemide; Humans; Natriuresis; Protein Binding; Rats; Rats | 1991 |
Effect of furosemide, hydrochlorothiazide and sodium restriction on rat adrenoceptors.
Topics: Animals; Binding, Competitive; Body Weight; Diet, Sodium-Restricted; Furosemide; Hydrochlorothiazide | 1991 |
Blood pressure and red cell sodium transport changes following salt load in patients with glomerulonephritis.
Topics: Adult; Biological Transport; Blood Pressure; Body Weight; Erythrocytes; Female; Furosemide; Glomerul | 1990 |
Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
Topics: Adult; Atenolol; Body Weight; Captopril; Creatinine; Female; Furosemide; Humans; Hypertension; Lupus | 1990 |
Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 2. Furosemide.
Topics: Adenoma; Animals; Body Weight; Brain Neoplasms; Carcinogens; Diuretics; Female; Furosemide; Hyperpla | 1990 |
Surfeit and deficit of sodium: evidence from studies of body sodium in rats.
Topics: Animals; Body Composition; Body Weight; Furosemide; Hydrochlorothiazide; Male; Natriuresis; Rats; Ra | 1990 |
Pharmacokinetics and dynamics of furosemide in the newborn piglet.
Topics: Aging; Animals; Animals, Newborn; Body Weight; Furosemide; Glomerular Filtration Rate; Infusions, In | 1990 |
Optimization of the therapeutic index by adjustment of the rate of drug administration or use of drug combinations: exploratory studies of diuretics.
Topics: Animals; Body Weight; Diuretics; Drug Combinations; Furosemide; Hydrochlorothiazide; Male; Models, B | 1990 |
Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bridged | 1989 |
Effects of aging on responses to furosemide.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Blood Pressure; Body Weight; Diuresis; Female; Fu | 1989 |
The effect of furosemide on intracranial pressure and hemorrhage in preterm rabbits.
Topics: Animals; Animals, Newborn; Body Weight; Brain; Cerebral Hemorrhage; Cerebrospinal Fluid; Cerebrospin | 1989 |
Is chloride depletion an important contributing cause of death in infants with bronchopulmonary dysplasia?
Topics: Acid-Base Imbalance; Body Weight; Bronchopulmonary Dysplasia; Cardiomegaly; Chlorides; Furosemide; H | 1986 |
Effects of volume change on circulating immunoreactive atrial natriuretic factor in rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Body Fluids; Body Water; Body Weight; Furosemide | 1987 |
The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study.
Topics: Adult; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Body Weight; Female; Furosemide; Heart Fa | 1988 |
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Clonidine; Dihydrala | 1986 |
[Pseudo-Bartter's syndrome induced by surreptitious ingestion of furosemide to lose weight: a case report and possible pathophysiology].
Topics: Adult; Bartter Syndrome; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Female; Furosemide; H | 1986 |
[Plasma renin activity and aldosteronemia in patients with simple obesity and in persons with normal body weight at rest and after stimulation with furosemide and upright posture].
Topics: Adult; Aldosterone; Body Weight; Female; Furosemide; Humans; Male; Middle Aged; Obesity; Posture; Re | 1988 |
Chronic hyponatremia associated with diabetic amyotrophy.
Topics: Atrophy; Body Weight; Demeclocycline; Diabetes Mellitus, Type 2; Electrolytes; Furosemide; Humans; H | 1986 |
Peripolar cells in the avian kidney.
Topics: Animals; Blood Pressure; Body Weight; Chickens; Desoxycorticosterone; Female; Furosemide; Kidney; Mi | 1988 |
Influence of furosemide treatment on fluid and electrolyte balance in horses.
Topics: Acid-Base Equilibrium; Animals; Blood Proteins; Body Weight; Calcium; Chlorides; Furosemide; Hematoc | 1988 |
Water uptake by Rana temporaria: effects of diuretics and the renin--angiotensin system, and nephrectomy.
Topics: Acetazolamide; Aldosterone; Animals; Body Weight; Captopril; Corticosterone; Drinking; Female; Furos | 1987 |
Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
Topics: Adult; Aged; Arginine Vasopressin; Blood Pressure; Body Weight; Captopril; Creatinine; Female; Furos | 1986 |
Tissue electrolyte changes induced by high doses of diuretics in rats.
Topics: Amiloride; Animals; Body Weight; Bone and Bones; Electrolytes; Furosemide; Heart; Male; Motor Activi | 1987 |
Diuretic-induced growth failure in rats and its reversal by sodium repletion.
Topics: Animals; Body Composition; Body Weight; Extracellular Space; Furosemide; Growth Disorders; Rats; Rat | 1987 |
Contribution of the urea appearance rate to diuretic-induced azotemia in the rat.
Topics: Adrenalectomy; Amino Acids; Animals; Body Weight; Corticosterone; Diet, Sodium-Restricted; Dietary P | 1987 |
[Clinical observation of a case of nephrotic syndrome].
Topics: Adult; Body Weight; Edema; Furosemide; Humans; Hypotension, Orthostatic; Male; Nephrotic Syndrome; S | 1986 |
Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.
Topics: Amiloride; Ascites; Body Weight; Chronic Disease; Diuresis; Edema; Electrolytes; Furosemide; Humans; | 1986 |
In vivo total body electrical conductivity following perturbations of body fluid compartments in rats.
Topics: Animals; Body Composition; Body Fluid Compartments; Body Fluids; Body Water; Body Weight; Burns; Ele | 1986 |
Probenecid potentiates the hyperglycaemic effect but reduces the diuretic effect of frusemide in mice.
Topics: Animals; Blood Glucose; Body Weight; Diuretics; Drug Synergism; Female; Furosemide; Glycosuria; Hype | 1986 |
Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
Topics: Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; | 1986 |
Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea.
Topics: Adult; Ascites; Body Weight; Creatinine; Drug Therapy, Combination; Edema; Furosemide; Humans; Hypon | 1986 |
Furosemide lowers intracranial pressure by inhibiting CSF production.
Topics: Animals; Animals, Newborn; Body Weight; Brain; Cerebrospinal Fluid; Furosemide; Intracranial Pressur | 1986 |
Growth failure and decreased bone mineral of newborn rats with chronic furosemide therapy.
Topics: Animals; Animals, Newborn; Body Weight; Bone and Bones; Bone Development; Calcium; Dose-Response Rel | 1986 |
Plasma corticosterone and volume after preoptic recess lesions and volume depletion.
Topics: Animals; Blood Volume; Body Weight; Corticosterone; Diet, Sodium-Restricted; Furosemide; Male; Natri | 1985 |
Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
Topics: Blood Pressure; Blood Urea Nitrogen; Body Weight; Calcium; Creatinine; Diuresis; Electrolytes; Furos | 1985 |
Muzolimine in chronic renal failure: a study in 16 patients.
Topics: Adult; Blood Pressure; Body Weight; Diuresis; Edema; Electrolytes; Female; Furosemide; Heart Rate; H | 1985 |
Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
Topics: Adult; Body Weight; Electrolytes; Female; Furosemide; Humans; Male; Muzolimine; Nephrotic Syndrome; | 1985 |
Clinical pharmacology of loop diuretics: a comparative study.
Topics: Adult; Ascites; Blood Pressure; Body Weight; Bumetanide; Diuresis; Diuretics; Electrolytes; Female; | 1985 |
Influence of diuretic-induced dehydration on competitive running performance.
Topics: Adult; Body Temperature Regulation; Body Weight; Dehydration; Diuretics; Furosemide; Humans; Lactate | 1985 |
Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.
Topics: Acetazolamide; Animals; Body Weight; Cisplatin; Creatinine; Diet; Furosemide; Glomerular Filtration | 1985 |
Does the in-utero exposure to furosemide delay the renal maturation?
Topics: Animals; Blood Chemical Analysis; Body Weight; Female; Fetal Organ Maturity; Furosemide; Kidney; Kid | 1985 |
Rapid correction of hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. An alternative treatment to hypertonic saline.
Topics: Adult; Body Water; Body Weight; Diuresis; Epilepsy, Tonic-Clonic; Female; Furosemide; Humans; Hypert | 1973 |
[Variation of the low frequency impedance of the human body during hemodialyses and therapeutic diuresis].
Topics: Body Water; Body Weight; Edema; Electric Conductivity; Extracellular Space; Furosemide; Humans; Intr | 1974 |
Diuretics, cardiac failure and potassium depletion: a rational approach.
Topics: Aged; Amiloride; Body Weight; Diet, Sodium-Restricted; Diuretics; Edema; Furosemide; Heart Failure; | 1974 |
Selective hypoaldosteronism with hyperkalemia.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Body Weight; Desoxy | 1972 |
Sodium retention versus renin-angiotensin system in experimental renal hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Furosemide; Hypertension | 1973 |
"In vivo radioimmunoassay" of aldosterone.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Aldosterone; Animals; Body Weight; Carbo | 1973 |
The influence of dietary potassium on the renin and aldosterone response to diuretic-induced volume depletion.
Topics: Adult; Aldosterone; Angiotensin II; Body Weight; Diet; Diuresis; Female; Furosemide; Humans; Male; N | 1974 |
Renin-angiotensin system and sodium homeostasis in Bufo arenarum.
Topics: Angiotensin II; Animals; Body Weight; Bufo arenarum; Furosemide; Homeostasis; Kidney; Male; Metaboli | 1971 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digital | 1972 |
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Body Weight; Cardiac Output; Female; Fu | 1972 |
Diuretic agents: inciting factor in nonocclusive mesenteric infarction?
Topics: Aged; Blood Urea Nitrogen; Body Weight; Digitalis; Diuretics; Female; Furosemide; Heart Failure; Hem | 1974 |
Calcium reabsorption in the thin loop of Henle.
Topics: Absorption; Animals; Blood Pressure; Body Weight; Calcium; Female; Furosemide; Hematocrit; Kidney Tu | 1974 |
The action of Taraxacum officinale extracts on the body weight and diuresis of laboratory animals.
Topics: Animals; Body Weight; Diuresis; Furosemide; Male; Plant Extracts; Plants; Rats | 1974 |
Plasma aldosterone in essential hypertension with low renin activity.
Topics: Aldosterone; Body Weight; Corticosterone; Cushing Syndrome; Furosemide; Humans; Hydrochlorothiazide; | 1974 |
Renal response to furosemide in critically ill patients.
Topics: Acute Kidney Injury; Aminohippuric Acids; Blood Flow Velocity; Body Weight; Diuresis; Furosemide; Hu | 1974 |
[Pathophysiology and treatment of burns illness (author's transl)].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Surface Area; Body Temperature; Body Weight; Burns; C | 1974 |
Pulmonary contusion. Pathogenesis and effect of various resuscitative measures.
Topics: Animals; Body Weight; Central Venous Pressure; Contusions; Dexamethasone; Dextrans; Dogs; Furosemide | 1973 |
Diuretic therapy in experimental right heart failure of the rhesus monkey.
Topics: Animals; Benzoates; Body Weight; Chlorothiazide; Diuretics; Edema; Furosemide; Haplorhini; Heart Fai | 1972 |
[Treatment of arterial hypertension with new drugs. 1. Severe arterial hypertension].
Topics: Antihypertensive Agents; Body Weight; Clonidine; Diuresis; Furosemide; Hemodynamics; Humans; Hyperte | 1972 |
Spironolactone as a nonspecific treatment for primary aldosteronism.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Body Weight; Carbon Dioxide; Creatini | 1973 |
Salt-poor human albumin in management of nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Albumins; Body Weight; Creatinine; Diet Therapy; Dietary Proteins; Edema; F | 1974 |
Large dose furosemide therapy for hypertension. Long-term use in 22 patients.
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Bod | 1974 |
High doses of furosemide and sodium in hypertension. A single therapeutic measure in severe cases.
Topics: Administration, Oral; Blood Pressure; Body Weight; Creatinine; Diet; Female; Furosemide; Humans; Hyp | 1974 |
Teratogenic action of carbonic anhydrase inhibitors in the rat.
Topics: Abnormalities, Drug-Induced; Acetazolamide; Acidosis; Animals; Body Weight; Carbonic Anhydrase Inhib | 1968 |
[Glucagon test and electrolytes in long term administration of furosemide to insulin requiring diabetics].
Topics: Aged; Amylases; Blood Glucose; Blood Pressure; Body Weight; Carbohydrate Metabolism; Diabetes Mellit | 1970 |
[Malignant arterial hypertension. Intensive treatment by acute sodium depletion and antihypertensive agents].
Topics: Adult; Antihypertensive Agents; Body Weight; Creatinine; Diet, Sodium-Restricted; Diuretics; Female; | 1972 |
Hypokalemia caused by surreptitious self-administration of diuretics.
Topics: Adjustment Disorders; Adult; Bicarbonates; Body Weight; Chlorides; Chlorthalidone; Chromatography, T | 1972 |
Hyponatremia due to sodium depletion in the absence of vasopressin.
Topics: Animals; Body Weight; Depression, Chemical; Diabetes Insipidus; Diet; Feeding Behavior; Female; Furo | 1972 |
Effect of chronic alteration of sodium balance on reabsorption by proximal tubule of the dog.
Topics: Animals; Body Weight; Dogs; Furosemide; Glomerular Filtration Rate; Inulin; Kidney Tubules; Potassiu | 1972 |
[Water-sodium depletion and clonidine in severe arterial hypertension].
Topics: Adult; Antihypertensive Agents; Body Weight; Clonidine; Creatinine; Drug Synergism; Electrocardiogra | 1972 |
Blood pressure in chronic renal failure. Effect of sodium intake and furosemide.
Topics: Adolescent; Blood Pressure; Body Weight; Creatinine; Diet; Diet, Sodium-Restricted; Female; Furosemi | 1972 |
[Use of high-dose furosemide in patients undergoing regular hemodialysis].
Topics: Body Weight; Creatinine; Diuresis; Furosemide; Headache; Humans; Injections, Intravenous; Kidney Fai | 1972 |
Accelerated reabsorption in the proximal tubule produced by volume depletion.
Topics: Aldosterone; Animals; Autoradiography; Body Weight; Diet, Sodium-Restricted; Extracellular Space; Fu | 1971 |
Scientific and medical aspects of the Australian Andean expedition.
Topics: Acclimatization; Adaptation, Biological; Altitude; Australia; Blood Glucose; Body Height; Body Weigh | 1971 |
Body hydration and the incidence and severity of acute mountain sickness.
Topics: Adult; Altitude; Blood Urea Nitrogen; Body Weight; Carbon Dioxide; Dehydration; Diuresis; Furosemide | 1971 |
Clinical experience with metolazone in fifty-two African patients: synergy with frusemide.
Topics: Adult; Black People; Body Weight; Diuretics; Drug Synergism; Edema; Female; Furosemide; Humans; Keto | 1971 |
Treatment of cor pulmonale decompensatum with diuretics.
Topics: Acidosis, Respiratory; Blood Gas Analysis; Body Weight; Diuresis; Diuretics; Drug Resistance; Drug S | 1971 |
Use of home-blood-pressure measurement to compare the efficacy of two diuretics. Effects of methylclothiazide and frusemide on blood pressure and plasma renin activity and electrolytes.
Topics: Adult; Ambulatory Care; Blood Pressure; Blood Pressure Determination; Body Weight; Electrolytes; Fem | 1971 |
[Triamterene-frusemide combination in edematous patients].
Topics: Adult; Ascites; Body Weight; Diuresis; Diuretics; Drug Synergism; Edema; Electrolytes; Female; Furos | 1970 |
The epidemiology o digoxin. A study in three Boston hospitals.
Topics: Age Factors; Aged; Aminophylline; Arrhythmias, Cardiac; Body Weight; Digoxin; Epidemiologic Methods; | 1969 |
[Modifications of glomerular filtration and the extracellular space in pregnancy toxemia by use of a diuretic].
Topics: Adult; Body Weight; Diuresis; Extracellular Space; Female; Furosemide; Glomerular Filtration Rate; H | 1969 |
Combined ascitic-fluid and furosemide infusion in the management of ascites.
Topics: Adult; Aged; Ascites; Ascitic Fluid; Bilirubin; Blood Proteins; Blood Urea Nitrogen; Body Weight; Cr | 1970 |
Observations of renal function in patients undergoing therapeutic diuresis with frusemide.
Topics: Aged; Blood Pressure; Blood Urea Nitrogen; Body Weight; Cardiac Output; Diuresis; Edema; Extracellul | 1970 |
Congestive heart failure. Clinical evaluation of furosemide in congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Body Weight; Female; Furosemide; Heart Failure; Humans; Male; Middle Ag | 1970 |
[Nutritional problems in intermittent continuous hemodialysis of chronic kidney patients].
Topics: Adolescent; Adult; Age Factors; Anabolic Agents; Blood Urea Nitrogen; Body Weight; Diet Therapy; Die | 1970 |
Congenital atrial flutter and cardiac failure presenting as hydrops foetalis at birth.
Topics: Atrial Flutter; Birth Weight; Body Weight; Digoxin; Edema; Electrocardiography; Female; Fetal Diseas | 1970 |
Frusemide in heart failure of infancy.
Topics: Administration, Oral; Aortic Coarctation; Body Weight; Chlorides; Ductus Arteriosus, Patent; Female; | 1971 |
Dual effect of potent diuretics on renal handling of phosphate in man.
Topics: Adult; Body Weight; Calcium; Ethacrynic Acid; Extracellular Space; Furosemide; Glomerular Filtration | 1971 |
A dynamic study of plasma renin activity and aldosterone concentration in normal and hypertensive subjects.
Topics: Adolescent; Adult; Aldosterone; Body Weight; Diuresis; Female; Furosemide; Humans; Hyperaldosteronis | 1971 |
[Clinical experience with a new spironolactone-thiabuzide combination].
Topics: Aged; Body Weight; Digoxin; Diuretics; Drug Synergism; Edema; Female; Furosemide; Glycosuria; Humans | 1968 |
Some physiological observations on the exocrine pancreas. The effects of some agents on pancreatic secretion.
Topics: Acetazolamide; Animals; Body Weight; Cats; Cholecystokinin; Dogs; Exocrine Glands; Furosemide; Gastr | 1968 |
A diuretic approach to acute withdrawal from alcohol.
Topics: Acute Disease; Alcoholism; Body Fluids; Body Weight; Chlorides; Diuresis; Erythrocytes; Furosemide; | 1969 |
Effect of acute diuresis on aldosterone secretion in edematous patients.
Topics: Adult; Aldosterone; Body Weight; Chlorides; Diet Therapy; Diet, Sodium-Restricted; Diuresis; Diureti | 1969 |
[On the management of renal acidosis using sodium bicarbonate and ethacrynic acid].
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adult; Bicarbonates; Blood Pressure; Body Weight; Etha | 1969 |
Newer diuretics in the treatment of cardiac or hepatic disease in elderly patients.
Topics: Ascites; Benzothiadiazines; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cardiovascular Diseases | 1966 |
Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arthritis, Experimental; Body Weight; Collagen Type | 2011 |
Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals.
Topics: Adipocytes; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Cholesterol; Diet; Dietary Fa | 2003 |